cn summer 2007
TRANSCRIPT
A QUARTERLY PUBLICATION OF CITY OF HOPE I VOLUME 18 NUMBER 3 SUMMER 2007
Transplantationtreatment fortype 1 diabetes
CityNewsInjectionProtectionVaccines take shots at a new array of diseases
$5 million ArgyrosFoundation giftmoves CITI forward
New drugs boosthope for breastcancer patients
R1_60085.Reader Spreads_Final 8/29/07 9:44 AM Page 1
Unlocking cancer’s secretsThere is good reason to feel optimistic about
the fight against cancer. Every day, researchersmove closer to unlocking the disease’s secrets.Along the way, their discoveries translate into newtherapies for patients with cancer and other
serious diseases. At City of Hope, we understand that peopleneed these therapies now.
Some of the treatments now in development rely on boostingthe power of the immune system: using the body’s own natural defenses against disease. As you will see in this issue,our investigators are developing vaccines to enhance theimmune system.
Not only are our scientists creating a vaccine that aims tofight tumors resulting from breast, colon, prostate and pancreaticcancers, but we also have started the initial clinical trials of thevery first vaccine developed at City of Hope. This vaccine targets adeadly herpes virus called cytomegalovirus, which can becomeactivated in patients with weakened immune systems, such asthose who have undergone bone marrow transplantation.
Taking such a vaccine to clinical trial takes persistence; creditgoes to scientists, physicians, technicians, trial volunteers and, ofcourse, the donors whose generosity supports such high-impact work.
Only an institution with a unique environment like City of Hope,which encourages researchers and physicians to continuallycollaborate and relies on the investments of dedicated philanthropists,can maintain the long-term commitment necessary to shepherdsuch projects. To paraphrase one of our researchers, there arefew places like this anywhere.
With your support, I feel confident that we will reach ourgoals in the fight to beat cancer.
Michael A. Friedman, M.D.President and Chief Executive Officer
Fulfilling a profound missionAs a part of City of Hope’s volunteer
movement for nearly three decades now, I have
witnessed many impressive advances at the
institution. During these years, City of Hope has
redefined the future of medicine with dramatic
new discoveries, improved treatments and expanded facilities. As
a result, more and more lives are being saved around the world.
The future looks even brighter. Guided by City of Hope’s
strategic plan, we are strengthening our leading role in cancer care
and research, locally and nationally, by expanding key programs.
We also are progressing in shortening the time from exploring
initial research ideas to developing new therapies. Recently, our
efforts were recognized with our inclusion on U.S.News & World
Report’s 2007 list of “America’s Best Hospitals.” (See story on page 14.)
From my initial involvement with City of Hope through the
Food Industries Circle, including a term as its president, to my
service as a member of the City of Hope board of directors, I not
only have been inspired by the remarkable breakthroughs, but also
by the incredible passion and dedication of many donors and
volunteers. Lifelong supporters who wholeheartedly embrace the
institution, and instill this special commitment in their children and
grandchildren, have created inspiring legacies that will touch lives
everywhere for generations to come.
My colleagues on the board of directors, another outstanding
group of supporters, bring a wealth of business, civic and
philanthropic experiences to help City of Hope become a new
model cancer center of the 21st century. I am privileged to lead
them in this noble endeavor.
Terry R. PeetsChair, City of Hope Board of Directors
Leadership Messages
CITY NEWS SUMMER 2007
City of Hope, an innovative biomedical research,treatment and educational institution, is dedicatedto the prevention and cure of cancer and other life-threatening diseases, guided by a compassionatepatient-centered philosophy, and supported by anational foundation of humanitarian philanthropy. © City of Hope
City News is publishedquarterly for donors,volunteers and friends of City of Hope.
BRENDA MACEOSenior VicePresident,Communications
KEVIN KOGAAssociate Vice President,Communications
STEVE KIRKEditor
ALICIA Di RADOStory Editor
KIM HOSOZAWAAssociate Director,Creative Services
ALICIA Di RADOCARMEN R. GONZALEZPAT KRAMERELISE LAMARSHAWN LEKATHLEEN O’NEILH. CHUNG SOWriters
R1_60085.Reader Spreads_Final 8/29/07 9:44 AM Page 2
CityNews
8 A new option for those facing metastatic
breast cancer One of the first medications in anew family of drugs pioneered byCity of Hope researchers appears toslow the progression of metastaticbreast cancer tumors.
10 Resetting theimmune system
to halt diabetesUsing bone marrowtransplantation toreplace malfunctioningimmune cells may offera new way to treat an all-too-prevalentdisease.
14 U.S.News & WorldReport affirmation
City of Hope is named as one of “America’s Best Hospitals” in two specialties on U.S.News’annual survey.
36 City of Hopeinvestigator receives
human stem cell grantTimothy O’Connor, Ph.D., professorin the Division of Biology, receivesone of the first grants to fund humanembryonic stem cell research underCalifornia’s Prop. 71.
2Injection protection: Applying vaccines in a whole new wayA rite of passage for most children, vaccines are now under exploration worldwide as aninnovative new way to prevent and even treat cancer and related diseases.
A Q U A R T E R L Y P U B L I C A T I O N O F C I T Y O F H O P E I V O L U M E 1 8 N U M B E R 3 S U M M E R 2 0 0 7
15Chapters: Celebrating a successful NationalConvention
28Arnold and Mabel BeckmanCenter moves research inimmunotherapeutics forward
29$5 million gift from the Argyros Foundation supports CITI
37“Celebration of Life” reunitesthousands saved throughtransplantation
CITY NEWS SUMMER 2007 I 1
R1_60085.Reader Spreads_Final 8/29/07 9:44 AM Page 3
2 I CITY NEWS SUMMER 2007
R1_60085.Reader Spreads_Final 8/29/07 9:44 AM Page 4
CITY NEWS SUMMER 2007 I 3ILLU
STRA
TIO
NS:
MA
RTIN
JA
RRIE
Facing the deadly plans of an evil villain, comic-book
characters rarely defend the planet as everyday
humans. Instead, they call on special powers that
turn them into hardnosed crime-fighters.
As it is when the body must defend against
disease. Sometimes the immune system simply
lacks the brawn to fight illness on its own. That is
when physicians draw on the power of vaccines —
injections that can give the immune system a
much-needed boost.
INJECTIONPROTECTIONVaccines take shots at a new array of diseases
By Elise Lamar
R1_60085.Reader Spreads_Final 8/29/07 9:44 AM Page 5
The goal of a vaccine — whether it aims to prevent an infectious disease suchas polio or means to stop cancer — is to motivate cells of the immune system intogetting so mad that they rise up and drive out harmful intruders.
Fortunately, cells usually do a pretty good job without prompting by aninoculation. Most of the time, when immune cells such as B-cells or T-cells spot anunwanted invader like a flu virus or a tumor cell, they mount a toxic response andneutralize it.
But every now and then — either because invaders are overpowering or becausedisease or therapy weakens the immune system — people need the backup boost of a vaccine.
Researchers worldwide are on a quest to harness the power of vaccines, andCity of Hope scientists are advancing the movement on two fronts: vaccines againstcancer and against diseases related to cancer treatment. They also are takinglessons learned from such research and applying them to other diseases, extendingthe reach of their work.
From friend to foeThe word “vaccine” often conjures up childhood memories of jabs in the arm againstmeasles, smallpox and other infectious diseases, and for good reason. Vaccinesbegan as protective measures, stoking the immune system to be ready to mount an offensive if exposed to specific infectious attackers.
Today, two approved vaccines related to cancer do just that. Meant for healthypeople, a hepatitis B vaccine defends against a virus that can cause liver cancer, andanother new vaccine called Gardisil protects against certain viruses that can causecancer of the cervix, throat and other areas.
But a newer, developing area in cancer vaccine research targets people whoalready have cancer. Called therapeutic vaccines, these injections aim to strengthenthe body’s defenses against existing tumors, keep tumors from returning or eliminatecancer cells that remain after other cancer treatments.
City of Hope surgical oncologist Joshua Ellenhorn, M.D., has his eye on onesuch therapeutic vaccine.
A surgeon also trained in immunology, Ellenhorn is developing a vaccine totarget cells that express high levels of a protein known as p53.
Normally, p53 plays a protective role as a tumor suppressor gene and actuallyblocks the out-of-control growth seen in many cancers.
But a mutation or damage to p53, which occurs in numerous cancers, deals cellsa double-whammy: Not only do the cells lose cancer protection normally offered bythe gene, but the defective p53 protein actually promotes tumor cell growth.
“Mutations in p53 that disable its ability to function as a tumor suppressorresult in accumulation of this protein within cells,” said Ellenhorn. “About 40 to 50percent of all malignancies overexpress mutant p53. In breast cancers, it is seen inapproximately 40 percent of all malignancies — same with colon, prostate andpancreatic cancers.”
Ellenhorn has created a vaccine he hopes will eradicate human tumors that expresshigh levels of mutant forms of p53. Interestingly, it is based on the prototype cowpox or“vaccinia” virus that English physician Edward Jenner famously pioneered 200 years agoas a vaccination against smallpox.
4 I CITY NEWS SUMMER 2007
Researchers
worldwide are
on a quest
to harness the
power of vaccines,
and City of Hope
scientists are
advancing the
movement on
two fronts.
R1_60085.Reader Spreads_Final 8/29/07 9:44 AM Page 6
Together with Don Diamond, Ph.D.,director of City of Hope’s Laboratory ofVaccine Research, Ellenhorn has used asimilar technique for a potential p53vaccine — but with a few moderntwists.
Just like Jenner, the City of Hoperesearchers are using cowpox virus tofire up the immune system. But intoday’s modern version, the scientiststweaked the cowpox virus’ genetic codeand plugged a copy of the p53 geneinto it.
Then they injected that specialvaccine — along with other therapiesthat also rev up immune response —into mice that had cancerous tumors.The result: Most of the tumors grewsmaller or disappeared altogether.
Because the engineered cowpoxvirus is foreign, it gets the attention ofthe immune system, Ellenhornexplained. “This then stimulates T- andB-cells, which are redirected towarddisintegrating and attacking tumors thatoverexpress p53.”
These findings show the vaccine
can kill tumors in mice. In a next step,the researchers successfully createdand tested a human form of the vaccinein mice, and tests in human cells in thelab have shown promise, too.
Ellenhorn is confident that thevaccine will soon reach clinical trials.“Initially, the phase I trial will be inpatients with advanced disease,” hesaid. “If the results are positive, wewould take it to a group of patients inan earlier stage of the disease.”
The donor gives twiceSometimes, the very therapies that helpa patient fight cancer are so potent thatthey themselves are life threatening.Treatment with immunosuppressantdrugs after bone marrow or organtransplant, for example, leavestransplant patients vulnerable toordinary germs that lie dormant inhealthy adults.
Several City of Hope researchersare devising vaccine therapies toencourage immune cells to fight thesegerms.
One such danger comes in theform of a herpes virus calledcytomegalovirus, or CMV. About 50 to 80 percent of adults in the UnitedStates have been exposed to CMV, but it causes few symptoms in healthyindividuals. In transplant patients with compromised immune systems,however, activated CMV may causelife-threatening pneumonia.
A team of City of Hope scientistsled by Diamond has developed avaccine to address that threat. Butinterestingly, care providers wouldadminister the vaccine to the organ orbone marrow donor, not the recipient.They aim to transfer lifesaving CMVimmunity — in addition to transplantedtissues — to the recipient.
According to Diamond, when thebone marrow transplantation programbegan at City of Hope in the 1970s,CMV infection was the main cause ofmost patient deaths. And althoughphysicians have provided antiviral drugswith moderate success, the treatmentsometimes can be difficult to deal with.
CITY NEWS SUMMER 2007 I 5
R1_60085.Reader Spreads_Final 8/29/07 9:44 AM Page 7
6 I CITY NEWS SUMMER 2007
“The antiviral itself causes such adverse events, it probably is less positive thanwe first imagined,” said Diamond. “If we could prevent those, we would really begetting to a treatment that is head and shoulders above anything out there forcancer transplant.”
The result: saved lives.Much like the p53 vaccine, Diamond’s group designed the CMV vaccine as an
altered form of the cowpox virus — but with genetic code from the CMV virusattached. When introduced into the body, the vaccine launches a chain of eventsthat activates the donor’s immune system against CMV.
Results from lab research suggest the immunity would stay elevated aftertransplant, protecting the recipient.
The U.S. Food and Drug Administration recently approved the first human trialof the CMV vaccine developed by Diamond’s group. That trial began with theinoculation of the first volunteer, a City of Hope employee, in May of 2007.Volunteers’ overall health and responses to the inoculation will be monitored toevaluate vaccine safety.
John A. Zaia, M.D., professor and chair of the Division of Virology, is theprincipal investigator of the CMV phase I clinical trial. “This is the first vaccinedeveloped at City of Hope that has been brought to clinical trial,” he said. “Hopefully,this signifies a new era in vaccine development here.”
Stephen J. Forman, M.D., Francis and Kathleen McNamara Distinguished Chairin Hematology and Hematopoietic Cell Transplantation, credits City of Hope forcreating a research climate where basic researchers like Diamond and cliniciansinteract.
“We are the institute that understands this virus,” said Forman, clinical directorof City of Hope’s Division of Cancer Immunotherapeutics & Tumor Immunology.“The original work identifying the signature viral immune proteins was done here inDon Diamond’s lab. That is the reason this work has been successful.”
Establishing garden-variety immunityViruses aren’t the only threats to immunocompromised patients. An innocent walkin a garden may expose them to spores of an ordinary, soil-dwelling fungus calledAspergillus fumigatus and cause a potentially fatal lung disease known asaspergillosis. Like CMV infection, Aspergillosis is no small threat.
According to City of Hope investigator James Ito, M.D., director of theDepartment of Infectious Diseases, the development of better antiviral drugstargeting other types of infection has left Aspergillus with an infamous distinction.“By default, the most devastating infections are now fungal infections,” he said.“They’ve always been around, but have moved up into first place now. In fact,Aspergillus is now the most deadly of all fungal infections.”
The gravity of the fungal threat is echoed by Markus Kalkum, Ph.D., Ito’scollaborator in developing an Aspergillus vaccine. “We all inhale several hundredAspergillus spores a day, usually without any negative impact on our health,” saidKalkum. “However, inhalation of spores can prove fatal to bone marrow or organtransplant patients taking immunosuppressive drugs.”
In 2002, Ito and Joseph Lyons, Ph.D., a scientist in the Department of InfectiousDiseases, took the first steps to create a vaccine when they inoculated mice with a
Vaccine
development
is clearly not
for quitters.
Devising strategies
encouraging the
immune system to
take a stand against
invaders takes long,
hard work.
R1_60085.Reader Spreads_Final 8/29/07 9:44 AM Page 8
CITY NEWS SUMMER 2007 I 7
mix of pulverized Aspergillus proteins,treated the mice withimmunosuppressants to mimicconditions of transplant patients, andthen exposed mice to a lethal dose offungal spores. The results weredramatic. “A hundred percent of themice died if we didn’t vaccinate them,”reported Ito, “but a significant numberof them survived if we did.”
Now, with Kalkum joining the team,the researchers have zeroed in on thespecific protein in that fungal vaccine“soup” that stimulates the immuneresponse. When they vaccinated micewith just that protein, it, like the mix,protected mice against the infectiousAspergillus.
The investigators’ next goal is toestablish antifungal immunity inimmunodeficient humans. Currently,they are identifying antibodies thathumans make to mold proteins todetermine which fungal proteinsstimulate that response. Althoughseveral years away, once a vaccine isdeveloped, it will likely be administeredlike the CMV vaccine to the bonemarrow donor and not the recipient.
From idea to realityMoving from an idea to a therapy is along haul, one that is appreciated bySimon Lacey, Ph.D., associate researchscientist in the Division of Virology.Lacey, who also worked on the CMVproject, is conducting experiments todetermine whether a vaccine mightwork against another virus reactivatedin immunosuppressed patients: BKvirus, or BKV for short.
More than 80 percent of Americanadults are infected with BKV, making iteven more prevalent than CMV. Likethose with CMV, few with BKV showovert signs of disease. However,reactivation of the virus in immuno-
compromised patients following organtransplant may cause an irritation of thelining of the bladder known as cystitis,even to the point of bleeding.
After a kidney transplant, potentimmunosuppressants required to blockrejection of the new kidney mayactivate the BKV — sometimes withserious consequences. “Approximately30 percent of transplant patients showsigns of elevated virus levels, 5 percentdevelop signs of kidney disease, andabout half of those people then lose the kidney,” explained Lacey.
When viral levels rise, a physician’sonly choice is to drop patients’ doses of immunosuppressive drugs. “It’s aconstant balancing act,” said Lacey.“The only approach is aggressivelymonitoring the virus in the blood.”
Together with transplant surgeonJennifer Singer, M.D., of the Departmentof Urology at UCLA, Lacey is nowtracking blood and urine samples fromkidney transplant patients. If they canbetter understand how certain patients’immune systems successfully fight BKVinfection, they might be able to createways to predict which patients are likelyto develop the disease. Their studiesalso could lay the groundwork forvaccine development.
So far, Lacey has shown thatvaccination with a portion of BKV canget immune cells to react in mice. Thefirst steps in humans are promising, as well. But he cautions that results arepreliminary. “The logical next step is toeither develop a good drug conveying a type of immunotherapy, or to developa vaccine to protect people,” said Lacey.“But you can’t do any of those without a better idea of what you are facing.”
Poised for the long haulVaccine development is clearly not for quitters. Devising strategies that
encourage the immune system to take astand against invaders is long, hardwork. Gardisil, the much-publicizedvaccine against cervical cancer thattargets human papillomavirus, tookmore than 20 years of developmentbefore becoming available last year.
But City of Hope excels intranslational research, a process thatmoves laboratory science into newmodes of prevention, diagnosis andtreatment — and then takes lessonslearned from patients back into the lab. This gives the institution a nimbleadvantage in areas such as successfulvaccine development, according toDiamond. “City of Hope is uniqueamong American research centers in that its philosophy is to encouragecooperation among basic scientists and physicians that leads to somethingtangible,” he said.
Forman echoes that optimism. “We have all the right people collectedat City of Hope — the patients, the lab expertise and the doctors,” he said.“There are few other places like thisanywhere.” � � �
R1_60085.Reader Spreads_Final 8/29/07 9:44 AM Page 9
8 I CITY NEWS SUMMER 2007
By Alicia Di Rado
No onewants tohear that
they haveadvanced cancer,but women facingmetastatic breastcancer may soonhave a newtherapy option intheir hard-pitchedfight against the disease. City of Hoperesearchers andcolleagues haveshown that one ofthe first membersof a new family of drugs appears to slow tumors’progression inthese women.
New family of drugs offers
R1_60085.Reader Spreads_Final 8/29/07 9:44 AM Page 10
RE
SE
AR
CH
A
ND
T
RE
AT
ME
NT
The drug is known as Vorinostat. In a phase II clinical trial, it stabilized cancergrowth in a small group of women whorecently were treated for stage 4 breastcancer. Stage 4 breast cancer is the mostadvanced stage of the disease and involvescancer spread to other organs.
The medication belongs to a family of drugs called histone deacetylase, orHDAC, inhibitors. These agents come fromadvances in the field of epigenetics, arelatively new line of research that studieshow genes are inappropriately “turned on” or “off” without any changes in geneticsequences themselves.
Unlike other recent anticancerstrategies that target altered genes andtheir gene products, epigenetic strategiesseek to turn on genes that have beensilenced — those genes that can help put the brakes on cancer.
The field of epigenetics can be tracedback to early work carried out by ArthurRiggs, Ph.D., director of City of Hope’sBeckman Research Institute, andcolleagues, said George Somlo, M.D.,professor and director of breast oncology in the Division of Medical Oncology &Therapeutics Research and the study’ssenior author.
In the Vorinostat study, participantstook the drug in a pill form twice a day fortwo weeks, then took a week off. Overall,side effects were mild and the drug was welltolerated, said Somlo, who also co-directsthe City of Hope Breast Cancer Program.
The drug stabilized tumor growth infour of the 14 women in the study. Onewoman remained on the drug for morethan 13 months after beginning treatment.“She was going on cruises and travelingaround the world,” said medical oncologistThehang Luu, M.D., the study’s principleinvestigator.
“We hope that this and other HDACinhibitors can provide a novel treatment
option as part of combination therapy —especially for women with triple-negativebreast cancers,” Luu said, referring tocancers that do not overexpress estrogen,progesterone or human epidermal growthfactor (HER2) receptors. Luu believesHDAC inhibitors and other drugs emergingfrom epigenetics will likely work best whencombined with drugs that battle cancerfrom several directions.
City of Hope investigators plan to join a phase II clinical trial for metastatic breastcancer patients that will test a combinationof Vorinostat, bevacizumab (an agenttargeting blood vessels that providenourishment to cancer cells) and Paclitaxel,a chemotherapy drug, Somlo noted.
Researchers are investigating severalHDAC inhibitors, including Belinostat (alsocalled PXD101), currently offered in a phaseII clinical trial for patients withmesothelioma and a phase I trial forpatients with advanced solid tumors. AndVorinostat is in phase II clinical trials atCity of Hope for two other cancers: non-Hodgkin’s lymphoma and bladder cancer.
The investigations come through theCalifornia Cancer Consortium, a NationalCancer Institute-funded cooperative thatunites City of Hope, the University ofSouthern California, UC Davis and theUniversity of Pittsburgh to conduct smallstudies of up-and-coming drugs.
“Science is moving quickly on thesetherapies,” Luu said. “We’d like to be ableto speed them to our patients as fast as we can.” � � �
ALI
CIA
DI R
AD
O
CITY NEWS SUMMER 2007I 9
�
Thehang Luu and George Somlo
for breast cancer patients
ILLU
STRA
TIO
N: G
IAN
PAO
LO P
AG
NI
HOPER1_60085.Reader Spreads_Final 8/29/07 9:45 AM Page 11
10 I CITY NEWS SUMMER 2007
RE
SE
AR
CH
A
ND
T
RE
AT
ME
NT
By Kathleen O’Neil
Call it the ultimateact of treason.
In type 1 diabetes,the immune systemturns against thebody it is meant toprotect, attackingfragile cells in thepancreas. Wounded,these cells can no longer produceinsulin. And if the disease goesuntreated, bloodsugar levels canspike dangerouslyhigh or plungeperilously low.
Scientists put
ILLU
STRA
TIO
N: N
EIL
BREN
NA
N
R1_60085.Reader Spreads_Final 8/29/07 9:45 AM Page 12
Some researchers are asking a
provocative question about type 1
diabetes: What if the immune system
could be reset, so that it stopped
attacking insulin-producing cells?
City of Hope researchers already
are on the case.
An innovative new way to treat
type 1 diabetes under investigation by
City of Hope researchers could reverse
the disease and enable patients to
begin making their own insulin again.
The method would use bone
marrow transplantation to replace
patients’ malfunctioning immune cells.
Results from a preclinical trial of the
treatment led by Defu Zeng, Ph.D.,
assistant professor in the divisions of
Diabetes, Endocrinology & Metabolism
and Hematology & Hematopoietic
Cell Transplantation, appeared in the
Feb. 13 issue of the Proceedings of the
National Academy of Sciences.
Experts today consider bone marrow
transplantation, or BMT, too risky for
conditions that are not immediately
life-threatening, since it requires patients
to undergo radiation or chemotherapy to
kill their own bone marrow and immune
cells before transplantation. Zeng and his
colleagues found a gentler way to prepare
a patient with diabetes to receive a BMT
using donated cells.
“This approach is exciting because
it has the potential to cure diabetes,”
Zeng said. “Since our pretransplantation
conditioning method is much less toxic, it
could allow bone marrow transplantation to
be used to treat a variety of autoimmune
diseases for which total-body radiation or
chemotherapy is too damaging to justify
the benefits.”
Zeng and colleagues conduct the
research in the Leslie and Susan Gonda(Goldschmied) Diabetes and Genetic
Research Center, a City of Hope building
opened in 1997 that significantly
expanded basic and clinical diabetes
research at the Duarte, Calif., campus.
Of the nearly 21 million people living
with diabetes in the United States, 5 to
10 percent have type 1. Although it can
develop at any age, type 1 diabetes most
commonly appears in children and young
adults. One in every 400 to 600 children
in the country has the disease.
Currently incurable, the disease must
be controlled with insulin injections.
Healthy people produce immune
cells, called T-cells, which attack foreign
material. But in those with type 1
diabetes, T-cells mistakenly attack
insulin-producing beta cells.
Through a BMT, though, physicians
may introduce healthy, functioning
immune cells from a donor, allowing beta
cells to slowly grow back and produce
insulin again.
The team’s ingenious BMT method
eliminates the need for damaging
chemotherapy or radiation by using an
antibody to inactivate the host’s immune
T-cells instead. The procedure allows
donated T-cells to kill the host’s T-cells —
so the donated immune cells can take
over the body’s defensive duties. Zeng
found that without any pretreatment, the
host’s T-cells kill the donated T-cells
within 24 hours. Researchers previously
used the same antibody, anti-CD3, in
clinical trials to prevent rejection of
transplanted organs.
Zeng’s method was successful in
preclinical trials in rodents: None of the
mice receiving BMT and anti-CD3
developed diabetes again, compared
to 89 percent of the control group.
Examination of their pancreases showed
that their insulin-secreting cells were also
free from attack by T-cells, while the
opposite was found in untreated mice.
The researchers will continue
preclinical testing to establish groundwork
for potential human clinical trials.
The National Institutes of Health
(NIH) and the Juvenile Diabetes Research
Foundation (JDRF) support the work.
Support from the Gonda Foundation has
been pivotal in diabetes research and
in developing City of Hope’s islet cell
transplant program, which has been
designated by the NIH and JDRF as
one of seven islet cell resource centers
in the nation. � � �
KA
TH
LEEN
O’N
EIL
CITY NEWS SUMMER 2007I 11
�
From left, Ivan Todorov, Chia-Lei Vivian Lin,Chunyan Zhang and Defu Zeng.
type 1 DIABETES in reverse
R1_60085.Reader Spreads_Final 8/29/07 9:45 AM Page 13
Gene machines find theanswers to
12 I CITY NEWS SUMMER 2007
MA
RKIE
RA
MIR
EZ
�
Rama Natarajan
For much ofher life as aresearcher,
Rama Natarajan,Ph.D., has soughtto understand the causes behind diabetes’complications andhow resultingcellular changescan damageorgans like theheart and kidney.
By Elise Lamar
Now, through a powerful technique used
to search the entire human genome
for genes that are either expressed or
silenced in different disease states,
Natarajan can identify molecular
transformations potentially underlying
diabetes’ harmful events.
That technology, known as “ChIP-
on-chip,” makes Natarajan, professor in
the Department of Diabetes, Endocrinology
& Metabolism, optimistic about finding
answers to the molecular mysteries
behind diabetes. “Five years back, I
wouldn’t have dreamt that such
approaches would be available for
our studies,” she said.
In a study published in the
March 5 issue of the Journal of BiologicalChemistry, Natarajan’s group identified
such changes in diabetes using the
technology. Led by Assistant Research
Scientist Feng Miao, Ph.D., the group
found that high glucose levels harmful
to pancreatic, blood vessel and immune
system cells are associated with what
are called epigenetic changes in several
genes associated with diabetes.
Inherited changes in gene expression
may occur in two ways. They either
happen through genetic mutations,
which damage the sequence of the DNA,
or by the way the DNA and its associated
proteins — known collectively as chromatin
— are “packaged” in a cell’s nucleus. These
are referred to as epigenetic changes.
One type of epigenetic alteration is
the addition of methyl groups to DNA or
proteins, in a process called methylation.
This often promotes the formation of
tightly coiled chromatin associated with
gene silencing, when genes are “turned
off.” In contrast, different modifications
that unwind or relax the DNA strand
can “turn on” gene expression.
When such changes occur,increased inflammation likely promotes
R1_60085.Reader Spreads_Final 8/29/07 9:45 AM Page 14
RE
SE
AR
CH
A
ND
T
RE
AT
ME
NT
many complications of diabetes,including heart and kidney disease, andnerve and vision problems. Natarajan
is investigating whether biochemicalmodifications that alter chromatin’sstructure may cause some of theseconditions.
Initially, the group analyzed
chromatin modification in certain cells of
the immune system. They examined two
different methylation patterns — one
associated with active genes and the
other with silenced genes — in cells
grown in conditions that mimic diabetes.
“Using ChIP-on-chip, in one shot
you can look at 12,000 genes and see what
kinds of changes occur in the two different
methylation patterns,” Natarajan said.
The group identified specific genes
of interest through the study. “We found
a lot of genes related to diabetes were
turned on,” said Natarajan.
When they analyzed chromatin from
the same type of immune cells drawn
from patients with diabetes, they saw
similar patterns. Among affected genes
were some associated with inflammation,
as well as an enzyme linked to insulin
signaling. Overall, concluded Natarajan,
after exposure to diabetes’ high-glucose
conditions, “protective genes are ‘down-
regulated’ and bad genes are being
turned on.”
The study was the first to find
variations in these particular methylation
patterns across the genome in diabetes;
other studies already under way at
City of Hope and around the world
seek similar illuminating patterns in other
diseases.
Miao, who pioneered the application
of ChIP-on-chip in the lab, sees this study
as a start to a deeper understanding of
diabetes. “We are one step closer to a
modern epigenetic study of diabetes,” he
said. “I hope this technology will lead to
new tests to diagnose diabetes and its
complications.”
Natarajan’s group will now analyze
entire gene families using cells from
diabetic patients. “We are looking at
these targets now for patterns and
certain pathways that are turned on,”
she said, “and are coming up with
gene networks that could be related to
inflammation as well as metabolic defects.”
The group conducts the research in
the Leslie and Susan Gonda (Goldschmied)
Diabetes and Genetic Research Center.
The center significantly expanded basic
and clinical diabetes research at
City of Hope when it opened in 1997.
Grants from the Juvenile Diabetes
Research Foundation and the National
Institutes of Health, as well as a General
Clinical Research Center grant from the
National Center for Research Resources,
funded the study. ���
ILLU
STRA
TIO
N: R
ON
CH
AN
CITY NEWSSUMMER 2007 I 13
disease amid thousands of bits of DNA
R1_60085.Reader Spreads_Final 8/29/07 9:45 AM Page 15
By Shawn Le
City of Hope has been namedone of “America’s BestHospitals” in two specialties by U.S.News & World Report.City of Hope ranked 30th onthis year’s list of top cancerhospitals and 29th on the list for urology. The institutionis one of only five centers inCalifornia, and one of only two in the Los Angeles area, to appear on the cancer list and one of only sixhospitals in California ranked in urology.
Complete rankings of the tophospitals are available online atwww.usnews.com and appearedin the July 23 edition of U.S.News & World Report magazine.
“It is gratifying that the dedication
of our health care professionals,researchers and staff are recognized on anational level by U.S.News & World Report,”said Michael A. Friedman, M.D., presidentand chief executive officer, City of Hope.“Our ranking among the country’s tophospitals for cancer and urology reaffirmsour commitment to rapidly finding newand better treatments for patients battlingcancer and other diseases.”
City of Hope is one of only 40institutions in the nation to be designatedas a Comprehensive Cancer Center by the National Cancer Institute (NCI). Toearn this elite designation, a center mustundergo a rigorous peer-review process,maintain a significant base of individuallyfunded research projects and be heavilyinvolved in community outreach, as well as meet other academic and publicservice requirements.
“Our designation as a top cancer andurology hospital was not earned solely bythe advances in medical science that arediscovered and developed at City of Hope,but also by the value we place oncompassionate care,” said AlexandraLevine, M.D., chief medical officer of
City of Hope. “We consider the needs of
our patients in the full sense, and
endeavor to provide excellence in all
aspects of their treatment and care.”
“America’s Best Hospitals” features
173 medical centers selected from 5,462
hospitals nationwide in 16 specialty areas.
U.S. News based its cancer hospital
rankings on several criteria that include
reputation among board-certified
physicians, mortality rate, the number
of Medicare patients discharged, the
ratio of nurses to patients, NCI and
nurse magnet hospital designations,
accreditation by the Foundation for the
Accreditation of Cellular Therapy, the
use of specific advanced technology,
the availability of certain patient
services and other factors. Urology
rankings were based on similar criteria
including reputation, mortality rate,
Medicare patient discharges, nursing
ratio, nurse magnet hospital designation,
presence of an on-site trauma center, the
use of advanced technology and the
availability of patient services. � � �
14 I CITY NEWS SUMMER 2007
CI
TY
O
F
HO
PE
R
EC
OG
NI
TI
ON
ONE OF “AMERICA’S BEST HOSPITALS” FORCANCER AND UROLOGY
U.S.NEWS & WORLD REPORT NAMES CITY OF HOPE AS
ONE OF “AMERICA’S BEST HOSPITALS” FORCANCER AND UROLOGY
R1_60085.Reader Spreads_Final 8/29/07 9:45 AM Page 16
Tradition strengthens ties with volunteersThis summer’s National Convention, “Building a Future of Hope,” celebrated fundraising successes and City of Hope’s continued growth and development. I enjoyed meeting and reuniting with many of you during thatweekend, and I hope that those of you in attendance benefited from the time together and went away feelingenergized and renewed.
During the meetings and events I attended at Convention, I was again reminded how City of Hope’sthousands of dedicated volunteers are such an integral part of its rich history. I know the special humanity andcompassion that makes City of Hope a unique place is largely due to the efforts of chapter members. Conventionis a reminder that generations of chapter supporters have created an important foundation for the institution.
This is one of the unique and wonderful aspects of City of Hope — the spirit of legacy that is handed downwithin so many families. It is tremendously gratifying to see children and grandchildren carrying on their parents’and grandparents’ volunteer efforts at City of Hope, and it is something in which you should all take great pride.Young people represent the future of philanthropy for the institution, and their continuation of your remarkableaccomplishments is the ultimate tribute to the achievements of all of City of Hope’s volunteers throughout itsstoried history.
As you serve as ambassadors for City of Hope in communities across the country, remember that manypeople, including faculty, administrators, staff and, most importantly, patients and their loved ones, are deeplyappreciative of all of your efforts.
Sincerely,
Kathleen Kane, Executive Vice President of Development and External Affairs
P.S. A special section with photos from this year’s Convention, complete with coverage of award winners, begins onpage 19 of this issue. I hope you enjoy reliving some Convention highlights.
N O R T H W E S T
S O U T H W E S T
M I D W E S T
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
�Cece Robman andher husband,Marvin
�Kathleen Kane
C I T Y N E W S
Chapters
CITY NEWS SUMMER 2007 I 15
Beloved volunteer and former employee Cece Robman remembered
TOM
BRO
WN
STEV
E RO
BMA
N
Christa Thomas, Chapters Managing Editor
Longtime City of Hope volunteer and employee CeceRobman died in January at age 88 in Los Angeles. Thedaughter of late City of Hope Board Chair Lou Tabak,Robman befriended hundreds of chapter members duringher lifetime.
As a board chair’s daughter, Robman grew upwatching City of Hope’s growth and expansion firsthand— exposure that influenced her own career path. InDecember 1979, she joined City of Hope’s staff as adirector of nursing practice and remained with theinstitution until 1994, when she left the organization as a national events executive coordinator. Her husband,Marvin, also a devoted volunteer, served as a City of Hope board member.
After her City of Hope employment ended, Robmanremained involved as a tireless volunteer, overseeingfundraising events, including Walk for Hope to CureBreast Cancer, Workout for Hope and Coupons for Hopein Southern California. The committed supporter alsoworked closely with the Apparel Industry Group, as well as its predecessor, the Merchants Club, for more
than 40 years.
Even when she no longer volunteered, Robmanremained closely aligned with City of Hope, maintainingcontact with scores of volunteers and employees. She tookspecial pride in bestowing her father’s namesake award tooutstanding volunteers at numerous National Conventions.
Guadalupe “Peng” Garbo, senior coordinator ofnational campaigns, worked with Robman for more than 13 years. “Cece always was pleasant, kind and, most of all, caring. I know many people affiliated with City of Hope will miss her. She was a great inspiration and a role model for many of us,” Garbo said.
Roz Phillips, associate vice president of development,also remembers her fondly. “Her effervescent personality,her calm demeanor and her ability to smooth over anydifficult situation were Cece’s personality trademarks,”Phillips said. “She was a true example of a lifelong devotedsupporter of City of Hope.”
Robman is survived by three grown sons: Steve,Mark and David.
R1_60085.Reader Spreads_Final 8/29/07 9:45 AM Page 17
N O R T H W E S T
S O U T H W E S T
Actress and author BrookeShields and mortgage industrypioneer Melissa L. Cohnwere feted at the East EndChapter/Jeanne Kaye League’sannual “Woman of the Year”luncheon, held May 8 at the Waldorf-Astoria Hotel in New York. More than$300,000 was raised for City of Hope through the event,
where more than 500attendees gathered to see theaccomplished women honoredwith Spirit of Life® Awards.
Shields, whose film careerhas spanned nearly two decades,accepted her award in honor ofher late father, Francis A. Shields.With the publication of her book,“Down Came the Rain: MyJourney Through PostpartumDepression,” she became a high-profile advocate for women’shealth issues. A Golden Globe-nominated performer, Shields isbest known for her televisionseries “Suddenly Susan” andfeature films including “The BlueLagoon” and “Endless Love.”
Fellow honoree Cohn, chief executive officer of The Manhattan MortgageCompany, often is cited as amortgage industry leader byThe New York Times and TheWall Street Journal and regularlyappears on news channels. Herentrepreneurial spirit led her to
found Manhattan MortgageCompany, now a premierresidential mortgage firm thatoriginated loans last year worth$5 billion. She also was honoredwith a Stevie Award for WomenEntrepreneurs in 2007. TheIsrael Cancer Research Fundrecently acknowledged hersupport of causes benefitingwomen and children with its“Woman of Action” award, and in 2005 she received TheRetreat Hope Award, an honorfrom The Retreat, a group thatsupports women experiencing domestic abuse.
Each year, the East EndChapter/Jeanne Kaye Leaguerecognizes women of distinguishedachievement and leadershipwho have made significantcontributions to their professionand community. Past honoreesinclude Fran Drescher, KellyRipa, Cindy Crawford, PaulaZahn, Mary Tyler Moore andKatie Couric.
C I T Y N E W S
Chapters
More than 300 guests gatheredto honor Sunny Isles Beach, Fla.,Mayor Norman S. Edelcup whenhe was recognized with The Spiritof Life®Award at the TrumpSonesta Beach Resort on Feb. 8.
Hosted by the long-standingPhyllis Dropkin Chapter, thefestive dinner raised more than$250,000 for City of Hope, makingthe event one of the group’s mostnotable achievements.
Dedicated City of Hope
supporter Rhoda Ehrlich,president of City of Hope’sSoutheast Regional Council,played a key role in the event’ssuccess. “Rhoda’s long andstoried support of City of Hope isto be commended,” said JoanWizner, senior director ofdevelopment in the Florida office.“She has been a dedicated leader in Florida for many years nowand truly deserves our heartfeltthanks for all of her efforts.”
East End Chapter/Jeanne Kaye League honors Brooke Shields, Melissa L. Cohn
�Rhoda Ehrlich and Norman S. Edelcup
Stories by Carmen R. Gonzalez
16 I CITY NEWS SUMMER 2007
Brooke Shields andMelissa L. Cohn
Phyllis Dropkin Chapter gala feting Sunny IslesBeach, Fla., mayor raises $250,000
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
TER
I BLO
OM
�
AN
DRE
W G
OLD
STEI
N P
HO
TOG
RAPH
Y
R1_60085.Reader Spreads_Final 8/29/07 9:45 AM Page 18
Supporters raise the stakes More than 300 supporters gathered for the InnerCircle’s first Racing for Hope event March 17 at SantaAnita Park, where more than $130,000 was raised forCity of Hope. Among the celebrities who attended theevent at the Arcadia, Calif., racetrack were actor FredSavage and Los Angeles KNBC-TV weatherman andcomedian Fritz Coleman, who served as emcee.Legendary Hall of Fame jockey Eddie Delahoussaye andhorse trainer Doug O’Neil attended the event, as well.
The Inner Circle is a group of distinguishedSouthern California executives, community leaders and entrepreneurs with a long history of supportingCity of Hope. Savage, best known for his role on “TheWonder Years,” also has starred in the television series
“Working” and in such feature films as “Vice Versa” and “The Wizard.” Delahoussaye is a two-timeKentucky Derby winner, seven-time Breeders Cupwinning rider and winner of the Preakness andBelmont Stakes.
N O R T H E A S T
S O U T H E A S T
M I D W E S T
When children learn about theimportance of philanthropy fromtheir parents, the lessons staywith them for the rest of theirlives. In the City of Hope family,such legacies are not uncommon,and may carry on for generations.
New York’s Teens for HopeChapter — which Jamie Fuld,Joey Kuhn, Jocelyn Levy, ErinSchwartz and Jon Steeleestablished in 2001 — serves asan inspiring example of suchintergenerational support. Thenew chapter’s roots lie in the EastEnd Chapter/Jeanne KayeLeague, a long-term chapter also located in New York.
Jamie Fuld and her brother Ryan are the thirdgeneration of their family to provide support for City of Hope. The siblings’ grandmother, Jeanne Kaye,is the chapter’s namesake. And their mother, LisaKaye Fuld, now serves as one of its co-presidents.
The creativity and vitality of the Teens for HopeChapter members show in their unique fundraisingideas. During one project, they sold flip-flop sandals to raise funds for the institution and to educate otherteens about the cause.
From its core membership, the Teens for HopeChapter has grown to include students from severalNew York-area high schools. With Ryan Fuld nowserving as president, the group boasts 39 active members.
“In a society that seems self obsessed at times, it is refreshing to see young adults so dedicated tohelping others,” said Harry Giordano, senior director of development. “Ryan, Jamie and their fellow chaptermembers advocate tirelessly with other youth
around Manhattan to raise funds and awareness forCity of Hope. It truly is an honor to work with them.”
Teens further an inspirational legacy
�
Teens for Hopemembers include(top row, from left)JT Della Femina,Ian Franklin, RyanFuld, Scott Levy,(bottom row, fromleft) Alex Witkoff,Zachary Witkoff,Jaclyn Chesner,Taylor Bloom andAaron Scheinfeld.
CITY NEWS SUMMER 2007 I 17
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
�Inner Circle PresidentStephan Tow (farright) honors Reneeand Marc Paul fortheir philanthropy.
TH
OM
AS
BRO
WN
R1_60085.Reader Spreads_Final 8/29/07 11:33 AM Page 19
SOUTHEAST:Fort Lauderdale, Fla. — City of Hope President and Chief Executive Officer Michael A.Friedman, M.D., joined more than 450 chapter members and volunteers on Feb. 16 at theSoutheast Region Annual Children of Hope Luncheon, where more than $13,000 wasraised for City of Hope. Chapter members also collected thousands of toys and books forpediatric patients at Joe DiMaggio Children’s Hospital in Hollywood, Fla. As part of thefestivities, members and volunteers also celebrated the 100th birthday of Gerry Bogatin,
the Palm Beach Chapter’s beloved founder and president.
Aventura, Fla. — Keynote speaker City of HopePresident and Chief Executive Officer Michael A.Friedman, M.D., addressed a special cocktail reception for major south Floridadonors and Northern Trust Bank clients on Feb. 15. Florida’s YoungLeadership Chair Kim Biller spoke at the gathering.
SOUTHWEST:Duarte, Calif. — More than 500 Lions Club members gathered on campus on March 25 for Lions’ Day to celebrate the service organization’s 50thanniversary supporting City of Hope. Guest speakers included Fouad R. Kandeel,M.D., Ph.D., director of the Department of Diabetes and Endocrinology &Metabolism. To date, Lions Club International has raised $4.5 million for City of Hope, as well as spearheading the creation of the Japanese Garden.
Mission Viejo, Calif. — With his son and granddaughter by his side, longtimeShelia Sporn Chapter member Jack Lieberman toured City of Hope aftercompleting a recent significant gift. Over the years, Leiberman has donated nearly$75,000 to City of Hope. During the 1960s, both Lieberman and his wife, Bea,were active members of the now-honorary Orange County, Calif., chapter.
Porterville, Calif. — The Porterville Chapter held its annual City of HopeSpectacular Gala honoring its late, past-president Frank “Buck” Shaffer for 45 yearsof chapter service. More than 1,200 supporters gathered at the Feb. 24 event toraise funds for City of Hope, and more than 200 entertainers performed at thetribute. Nine-year-old Marshall Cotta, a former City of Hope pediatric patient fromSan Diego, also spoke about Shaffer’s recommendation that he seek treatment forhis brain tumor at City of Hope — a referral that ultimately saved his life.
NORTHEAST:Philadelphia — Bob Rovner, former Pennsylvania senator and assistant district attorney,recently was acknowledged as the Rissie Markowitz Chapter’s 2007 Spirit of Life® honoree.Honored because of his many achievements in politics, private philanthropy and broadcastcommunication, Rovner was recognized at a gala on June 6, which raised $80,000.
Collingswood, N.J. — The South Jersey Hope Chapter hostedits Annual Hope Dinner Dance and Auction on March 10 at theCollingswood Ballroom with more than 400 supporters inattendance, raising more than $50,000 for City of Hope.
M I D W E S T
N O R T H E A S T
S O U T H E A S T
Regional Roundup Chapter News From Around the Country
18 I CITY NEWS SUMMER 2007
C I T Y N E W S
Chapters� From left, Howard
Lieberman, JackLieberman andWendy Lieberman.
� From right, South Jersey Hope Chapter supporters Roxeen Froio, KathyMiddleton, Jill Walters, Marybeth Nolan and Vicky Thorp
Michael FriedmancongratulatesGerry Bogatin.
�� From left, MichaelFriedman, ToniNathan, Kim Biller,Ricky Paskow andMichael Yavner,wealth strategicvice president,Northern TrustBank.
� Bob Rovner
Lions Club members tour campus.�
Buck Shaffer�
R1_60085.Reader Spreads_Final 8/29/07 9:45 AM Page 20
Nearly 800 volunteers from across the country shared their
fundraising successes and learned about the latest advances
in medical research at City of Hope’s 2007 National
Convention in Beverly Hills, Calif., in June.
CONTINUED ON NEXT PAGE
From left, Bob Marx accepted the Gold award on behalf of the Board ofGovernors Chapter, Susan Rosman accepted the Bronze award onbehalf of the Medical Center Aides Chapter, and Sandy Hoffmanaccepted the Silver award on behalf of the 500 Club Chapter.
THE BENHOROWITZAWARDSrecognizethe highestlevel ofplannedgivingachieved by a chapter.
CITY NEWS SUMMER 2007 I 19
NATIONAL CONVENTION CELEBRATES CONTRIBUTIONS OF
VOLUNTEERSNATIONWIDE
R1_60085.Reader Spreads_Final 8/29/07 9:45 AM Page 21
Held at the Beverly Hilton Hotel,
the three-day convention — themed
“Building a Future of Hope” —
recognized the
significant
and ongoing
contributions
of auxiliary
members from scores of chapters
nationwide. The highly anticipated
gathering also enabled them to celebrate
their fundraising achievements and hear
inspirational messages from City of Hope
leaders and patients.
The convention began on June 23,
when City of Hope President and Chief
Executive Officer Michael A. Friedman,
M.D., and outgoing Board Chair Philip L.
Engel welcomed delegates at the
opening banquet.
The next day, at one of the more
popular convention activities, nearly
300 conventioneers traveled to the
Duarte, Calif., campus to hear faculty
members talk about research and
treatments. City of Hope patients also
shared their own stories of hope and
healing at the event, called the “Day of
Discovery.”
2007 NATIONAL CONVENTION
Adrienne Stern, left, wasrecognized for raising the mostindividual donations, while JaniceCohen received the award onbehalf of the Children’s LeukemiaChapter for most chapter fundsraised.
THE BRAVO!AWARDS recognizeoutstandingfundraising onbehalf of Walk for Hope to CureBreast Cancerbetweenconventions.
Front row, from left, Bea Wolfe,Monterey Park Chapter; PattiNewby, Donnez Nous Chapter;Lorraine Santoro, Phyllis DropkinChapter; Joan Stein, BerniceChernove Chapter (back row, fromleft) Eileen Stern, Desert Women’sCouncil Chapter; Bill Miller, Gift ofLife Chapter; Bob Marx, Board ofGovernors Chapter; Ira Sax,Children’s Leukemia Chapter; andFrancine Cohen, Seattle Chapter.
THE LOUIS TABAKAWARDS recognizechapter members for their outstandingindividual fundraisingefforts and chapterleadership qualities.
CONTINUED ON PAGE 22
20I CITY NEWS SUMMER 2007
The Circle of Hope Chapter, which is not represented in the photo, alsowon a Tabak Award.
R1_60085.Reader Spreads_Final 8/29/07 9:46 AM Page 22
Norm Crosby and Florence Henderson
Izzy Freeman and Sharon Berrickco-hosted Roll Call.
From left, Beverly Horowitz and herchildren Zach and Jody
6.
23
.0
7
-
6.
25
.0
7
CITY NEWS SUMMER 2007I 21
The All-American Boys Chorus performed an upbeat medley of tunes on Sunday evening.
Saturday’s opening events were co-hosted by Bonnie Fein and herbrother, Michael Kaplan.
Alexandra Levine delivers her address.
From left, Steve, David and MarkRobman, sons of decades-longsupporter, Cece Robman, andgrandsons of Lou Tabak.
R1_60085.Reader Spreads_Final 8/29/07 9:46 AM Page 23
2007 NATIONAL CONVENTION
22 I CITY NEWS SUMMER 2007
On the convention’s final day,
participants attended Hope Forum, a
series of educational sessions that
focused on fundraising tools and
strategies, as well as the traditional Roll
Call, where chapter members report on
fundraising results since the last
convention. At an evening dinner gala,
Peets addressed the conventioneers.
“One of the best aspects this year
was the addition of so many new faces —
chapter members who had never been
to a convention before,” said Roz
Phillips, associate vice president of
Development. “They really brought a
new energy to
all of the events.
I know they and
many other
attendees have
helped to
revitalize their
own chapters
with the renewed sense of purpose and
dedication they took back home
with them.”
Among the hosts at the three-day
event were longtime legacy supporters
Bonnie Fein and her brother, Michael
Kaplan; Ambassador Leadership
Izzy Freeman, right, presented hisnamesake award to longtime City of Hope champion Andy Spiegl.
THE “IZZY”AWARD recognizesone individual’sextraordinarydedication to City of Hope.
CONTINUED ON PAGE 24
On Monday night, sisters Kathy Kaye, left, and Lisa Fuld, whose mother foundedthe East End Chapter/Jeanne Kaye League of New York, hosted the gala event.
Patient speaker Beverly Austin
Mike Hersch and his grandson,Oliver Berger
Ernie So and his guest, ElissaBong
R1_60085.Reader Spreads_Final 8/29/07 9:46 AM Page 24
6.
23
.0
7
-
6.
25
.0
7
Barry Tyson accepted for the Angels ofHope Chapter.
Morrie Darnov accepted on behalf of theGift of Life Chapter.
Joan Perry, left, and Janice Brumeraccepted the award on behalf of theDonnez Nous Chapter.
Sandy Hoffman accepted the award onbehalf of the 500 Club Chapter.
CITY NEWSSUMMER 2007 I 23
Norman Crosby, right, presented his namesake award to Maurice“Morrie” Darnov, who thanked hisdaughter, Sharon, for her ownsupport of City of Hope.
Norman Beals accepted on behalf of theDershewitz/Aid to Life Chapter.
THE NORMAN CROSBYGOODWILL AMBASSADORAWARD acknowledges an outstanding volunteer who provides tireless support and kindness, and exhibits a benevolent spirit.
Ambassador Leadership Councilmembers Pat Perrott and Don Hoffmanhosted Sunday evening’s gathering.
Patient speaker Susanna Sawydan
Philip L. Engel,center, iscongratulatedby Michael A.Friedman, left, and Chair TerryPeets after he accepted anaward on Mondaynight in recognitionof his tenure.
INCOMING AND OUTGOING CHAIRS
THE SAMUEL H. GOLTERAWARDS highlightextraordinary gains in chapterfundraising betweenconventions.
Three chapters won Golter awards but were not represented at Roll Call: The Diamonds of the Desert Chapter,the Faith Guild TSSL Chapter and the Fred and Gertrude Rosen Tucson Chapter.
R1_60085.Reader Spreads_Final 8/29/07 9:46 AM Page 25
2007 NATIONAL CONVENTION
Council members Don Hoffman and Pat
Perrott; and New York-area supporters
and sisters Lisa Fuld and Kathy Kaye.
Other hosts and presenters included
Norm Crosby, City of Hope’s National
Ambassador of Goodwill, Florence
Henderson, the institution’s Star of
Hope; Board of Regents member Bobbie
Stern and former City of Hope patient
Dale Shartsis.
Monday’s traditional Roll Call was
led by board member Israel “Izzy”
Freeman and Ambassador Leadership
Council member Sharon Berrick, and
accompanied by legendary game show
host Monty Hall and Crosby.
“This convention would not have
been possible without the enthusiasm
and dedication of convention planning
committee members from here in
Southern California, as well as around
the country,” said
Alan Levey, senior
vice president
of development.
“You deeply
inspired me and
everyone else
who attended
this year’s
convention.”
Joseph P. Sanford
SIX OUTGOING DIRECTORS were honored fortheir leadership, support and ongoing, dedicatedservice on City of Hope’s board of directors.
Jack R. Suzar
Stephen B. Kass Claire L. Rothman
Israel “Izzy” Freeman Robbin L. Itkin
24 I CITY NEWS SUMMER 2007
Rhoda Makadon
R1_60085.Reader Spreads_Final 8/29/07 9:47 AM Page 26
Timothy Wilson, M.D., director, Department ofUrology/Urologic Oncology and the City ofHope Prostate Cancer Program, accepted theGallery of Achievement Award for Medicinefor outstanding contributions in the field ofurologic oncology.
Shiuan Chen, Ph.D., professor/director of theDepartment of Surgical Research, acceptedthe Gallery of Achievement Award forScience for outstanding contributions in thefield of breast cancer research.
GALLERY OF MEDICAL ANDSCIENTIFIC ACHIEVEMENTAWARDS
Pat Perrott presents her family’s namesake award to LoringLeeds, a stalwart City of Hope supporter.
THEPERROTT“VOICES OF HOPE”AWARDrecognizesremarkablededication to informing and inspiringothers about City of Hope’smission.
HOPE FORUM
6.
23
.0
7
-
6.
25
.0
7
CITY NEWSSUMMER 2007 I 25
Bobbie Stern and Dale Shartsis co-presented awards on Sunday evening.
R1_60085.Reader Spreads_Final 8/29/07 9:47 AM Page 27
2007 NATIONAL CONVENTION
26 I CITY NEWS SUMMER 2007
Joanne McKenzie, left, andNancy Jo Flint
From left, Salma Erlich, RichardErlich and Elaine Bloom
Richard Ziman, left, Kathleen Kane and Sid Kline
Lois and Don Bailey Lee and Shelly Greenberg
DAY OF DISCOVERY
Patient family speaker Bill Cloershared his story of hope and healing.
Monty Hall and Steve Gorelick
Michael A. Friedman, left, Rhonda Fleming and her husband, Darol Carlson
CONVENTION PHOTOGRAPHERS: TOM BROWN, AMY CANTRELL AND MARKIE RAMIREZ
R1_60085.Reader Spreads_Final 8/29/07 9:47 AM Page 28
RE
SE
AR
CH
A
ND
T
RE
AT
ME
NT
RIGHT ONTHE NOSE
Thankfully, surgery has greatlyadvanced over the millennia.
Today, neurosurgeons such as BehnamBadie, M.D., director of the Brain TumorProgram at City of Hope, have perfectedhighly sophisticated techniques to operateon the brain through the nose to removepituitary tumors as gently as possible.
Badie has unique expertise in thestrategy, dubbed the endonasal transsphenoidalapproach.
As Badie explains, tumors and cysts mayarise in the pituitary gland or in the tissuesurrounding it, called the sellar region. Thearea lies behind the nose and sinus. Althoughonly 10 to 15 percent of all brain tumors arepituitary tumors, and most of these arebenign, they can cause troublesomehormonal and neurological symptoms thatcan be relieved through surgery.
Few surgeons have the mastery andequipment to operate using the latest, mostprecise endonasal methods, which offeradvantages over earlier approaches.
“For years, surgeons were using whatwe call the sublabial-transseptal approach,where incisions are made through the upperlip and the septum of the nose — thecartilage — to access the brain,” said Badie,who has performed more than 200pituitary procedures. “This offered lessfacial scarring than earlier techniques, butpatients still experienced post-surgicaltrauma. And patients could be left withseptal perforation and permanent damage
to the sinuses.”The newer endonasal approach,
developed within the last decade, unites the visual precision of a slim, tiny camera,called an endoscope, with the power of anavigation system, magnetic resonanceimaging and highly specialized microscopes.The equipment in City of Hope’s operatingroom magnifies the tight surgical field whilethe StealthStation AXIEM electromagneticnavigation system guides surgeons to theirtargets, much like a global positioningsystem, or GPS, in a car.
The system provides stereotaxy — theability to pinpoint important structuresthree-dimensionally in the brain — withoutrequiring a patient’s head to be held inplace within a rigid frame.
Research indicates that the endonasalapproach is as effective as the sublabial-transseptal technique in removing pituitarytumors, and patients experience less painthrough the endonasal approach.
“The combination of the endoscope,operating microscope and framelessstereotaxy has improved the endonasaltranssphenoidal procedure by freeing thesurgeon’s hands, while also providingstereoscopic visualization,” Badie said.“Using these devices reduces operatingtime and provides easier control ofbleeding. As a result, my patients have notexperienced any cosmetic complications ornasal perforations, and most patients aredischarged home within 48 hours.”
Besides his successful procedures atCity of Hope, Badie also has contributed tothe surgery’s effectiveness worldwide. Heinvented two surgical instruments used inthe transsphenoidal procedure: the BadieSuction Bipolar Forceps, which a surgeonmay use to both grasp tissue and clean the surgical area, and the Badie SellaconPlate, a reabsorbable plate that is used toreconstruct the sella after surgery.
He also has published numerousarticles on the endonasal transsphenoidalapproach, including a chapter in the“Neurosurgical Operative Atlas — Neuro-Oncology,” an American Associationof Neurological Surgeons textbook herecently edited.
More information about the pituitary surgery technique is availableon the program’s Web site,www.cityofhope.org/braintumor. � � �
Behman Badie operates on pituitary tumorsendoscopically through the nose, resulting inless post-operative pain for patients.
Some 5,000 years ago,ancient Egyptians were thefirst to operate through thenasal passages. Their surgicaldevice: a special hook that,when inserted through a nostril, allowed morticians to remove brain matter forthe mummification process.
By Pat Kramer and Alicia Di Rado
©20
07 P
HIL
IP C
HA
NN
ING
CITY NEWSSUMMER 2007 I 27
�
R1_60085.Reader Spreads_Final 8/29/07 9:47 AM Page 29
On May 10, the drive to build theArnold and Mabel Beckman Center forCancer Immunotherapeutics and TumorImmunology began in earnest.Representatives from the Arnold andMabel Beckman Foundation and City of Hope broke ground on the newcenter, which will support research intothe cancer-fighting potential of theimmune system. More than 150 facultymembers, elected officials, boardmembers and other dignitaries attendedthe campus event.
The five-story, 108,000-square-footfacility will serve as headquarters forinvestigators in the Division of CancerImmunotherapeutics & TumorImmunology, or CITI. These scientistsstudy how cancerous tumors avoid theimmune system and, in turn, how toharness the immune system againstcancer. The center also will house
City of Hope’s Graduate School ofBiological Sciences.
“None of this would be possiblewithout the generous and visionary giftfrom the Arnold and Mabel BeckmanFoundation,” said Michael A. Friedman,M.D., president and chief executiveofficer of the institution, who noted theconstruction symbolizes an “era ofgrowth and expansion for City of Hope.”
The Arnold and Mabel BeckmanFoundation donated $20 million in 2006as the lead gift in a campaign to establishthe center. In 1983, the foundationinvested $10 million to establish andendow Beckman Research Institute ofCity of Hope — the first of five suchinstitutes nationwide — and thefoundation’s annual gifts have supportedthe continued growth of the institute.
“I think the whole foundation isexcited to be a part of this,” said Patricia
Beckman, daughter of Arnold and MabelBeckman. “I know I am.”
Ambassador George L. Argyros,chair of the board of the Arnold andMabel Beckman Foundation, also spoke at the groundbreaking, praising City of Hope’s ongoing research efforts. “I know that my dear friends Arnold andMabel Beckman would feel that theirmoney was well spent,” Argyros said.
During the ceremony, City of Hopechair emeritis Philip L. Engel announcedthat Argyros and his wife, Julia, alsopledged $5 million for the facility throughThe Argyros Foundation. (See the storyon page 29.)
City of Hope research leaders areenthusiastic about the science the giftswill support. Arthur Riggs, Ph.D., directorof Beckman Research Institute andprofessor of biology, noted that some ofthe research projects under way by CITIfaculty may seem like science fiction —such as engineering T-cells to attackcancer — but they are already in clinicalstudies. “The center will promoteabsolutely outstanding research, both basicresearch and clinical trials,” Riggs said.
Theodore Krontiris, Ph.D., director of City of Hope Comprehensive CancerCenter and executive vice president ofmedical and scientific affairs, said thecenter and CITI represent fulfillment ofthe institution’s three most importantmissions: discovering biological diseasemechanisms, speeding treatments toclinical trials and patient care, andfostering future scientists. � � �
From left, Arthur Riggs, Patricia Beckman,Michael A. Friedman, George L. Argyros, PhilEngel, Harry Gray and Andrew Raubitscheckwere among those to break ground for City of Hope’s new immunotherapeutics facility.
�
PAU
LA M
YER
S
Arnold and Mabel Beckman Center ushers in new era in
IMMUNOTHERAPEUTICS RESEARCHBy Alicia Di Rado
Their shovels crunched through the earth, metal against soil, lifting and sifting pebbles and sand.Soon, beams and columns will rise from that earth, forming the skeleton of a structure that willhouse researchers striving to bring an end to cancer.
28 I CITY NEWS SUMMER 2007
R1_60085.Reader Spreads_Final 8/29/07 9:47 AM Page 30
City of Hope leaders announced thegenerous gift during the building’s May10 groundbreaking, where AmbassadorGeorge L. Argyros was an honored guest.Argyros serves as chair of the board ofthe Arnold and Mabel BeckmanFoundation, which provided $20 millionin 2006 as the lead gift in a campaign to build the center.
“We are privileged to contribute to the ongoing efforts of City of Hope’sprominent researchers who arepioneering innovative technologies andbasic science discoveries towards newforms of treatment,” said Argyros, whooversees the Argyros Foundation with his wife, Julia. “This center will speed the outstanding work of City of Hopescientists directly to the hands ofphysicians to benefit patients morequickly than ever before.”
Michael A. Friedman, M.D., president and chief executive officer of City of Hope, noted that the gift will spurmore than construction of a building.“This generous gift will have an enormousimpact on the lives of patients battlingserious diseases,” Friedman said. “TheArnold and Mabel Beckman Center forCancer Immunotherapeutics and TumorImmunology will provide a venue forspecialists to share ideas and acceleratethe pace of scientific discovery.”
The 108,000-square-foot facility,designed by architect Ralph E. Johnson,will house researchers in the Division ofCancer Immunotherapeutics & TumorImmunology, or CITI. These scientistsstudy how cancerous tumors avoid the immune system and, in turn, how to harness the immune system againstcancer. CITI investigators conduct what is known as translational research,an approach that encouragescommunication between basic scientistsand clinicians to speed new treatmentsfrom the lab to the clinic.
The new facility, which also willhouse the Graduate School of BiologicalSciences, is scheduled for completion in 2009.
Argyros, an accomplished OrangeCounty businessman and former UnitedStates Ambassador to Spain from 2001to 2004, has served on many boards and
received numerous awards, including the Horatio Alger Association ofDistinguished Americans, an honor heshares with other successful figures whorose from humble beginnings, includingRonald Reagan and Oprah Winfrey.
Born in Detroit, Argyros grew up in Pasadena, Calif. He earned a degree in business and economics in 1959 from Chapman College, where he laterserved as the longest-serving chairman of the board of trustees from 1976 to 2001.
He is chairman and chief executiveofficer of Arnel & Affiliates, a prominentWest Coast diversified investmentcompany, and serves as general partnerin Westar Capital. He was formerly co-owner of AirCal, from 1981 to 1987, and the owner of the SeattleMariners Baseball Club from 1981 to 1989. � � �
CIT
I IM
AG
E
By Elise Lamar
The Argyros Foundation hasdonated $5 million towardconstruction of the Arnold andMabel Beckman Center forCancer Immunotherapeuticsand Tumor Immunology.
The Arnold and Mabel Beckman Center for Cancer Immunotherapeutics and Tumor Immunology�
ARGYROS FOUNDATIONsupports Arnold and Mabel Beckman Center with $5 million gift
CITY NEWS SUMMER 2007 I 29
R1_60085.Reader Spreads_Final 8/29/07 9:47 AM Page 31
By Kathleen O’Neil
As just about anyone who has
undergone chemotherapy can
attest, traditional cancer-killing
drugs can damage healthy
tissue, too. Gastrointestinal
problems, hair loss, fatigue
and other effects can
accompany chemotherapy’s
cancer-battling work. But now City of Hope researchers and
their colleagues may have found a way tofocus chemotherapy more specifically oncancerous tissue. That may mean not onlyless toxic treatments, but also moreeffective ones.
Investigators at City of Hope and St. Jude Children’s Research Hospital areusing modified neural stem cells to activateand concentrate chemotherapeutic drugspredominately at tumor sites, so thatnormal tissues surrounding the tumorsand throughout the body remainrelatively unharmed.
The investigative technique couldhelp increase the chemotherapy doses thatpatients can safely tolerate, potentiallyincreasing their cancer-cell-killing power.That may potentially bring good news forpatients with advanced cancers that havespread.
“This approach could significantlyimprove future treatment options forpatients with metastatic cancer,” said KarenAboody, M.D., assistant professor in thedivisions of Hematology & HematopoieticCell Transplantation and Neurosciences atCity of Hope. “It not only has the potentialto destroy residual tumor cells, but itshould also improve patients’ quality oflife by minimizing toxic side effects such as nausea, diarrhea or bone marrowsuppression.”
Aboody was the lead author of thestudy done in collaboration with seniorauthor Mary Danks, Ph.D., associatemember in the Department of MolecularPharmacology at St. Jude Children’sResearch Hospital in Memphis, Tenn. Thestudy was published in PLoS ONE, and asecond, related paper appeared in Cancer Research.
Most chemotherapy drugs damagefast-growing cells in the body — whethercells are normal or cancerous — which is why the drugs are toxic to tissues such as the intestinal lining and hair follicles.
Aboody and her colleagues havedeveloped a two-part system that mayreduce that toxicity. It first infiltrates tumorsand then activates a chemotherapeutic drug,providing a killing effect at the tumor site— or sites, if the tumor has spread. Thetechnique takes advantage of thetendency for invasive tumors to attractneural stem cells.
In their study, the researchers injectedmodified neural stem/progenitor cells intoimmunosuppressed mice with neuroblastomatumors. After waiting a few days to allowthe stem cells to migrate to the tumors,researchers administered a compound thatinteracts with an enzyme produced by theneural stem/progenitor cells. That compoundconverts into an active drug that killssurrounding tumor cells.
The precursor drugs were administeredfor two weeks. Then, after a two-weekbreak, researchers administered a secondround of stem/progenitor cells and drugs.
All of the neuroblastoma mice appearedhealthy and tumor-free at six months. All of
the untreated neuroblastoma mice diedwithin two-and-a-half months.
The results hold promise for treatingsolid tumors that metastasize, includingneuroblastoma, which represents 6 to 10percent of all childhood cancers worldwide,with higher incidence in children under age two.
“The results are especially important in the case of high-risk neuroblastoma,because treatment-resistant cancer returnsin as many as 80 percent of children, andthe majority die of their disease,” Danks said.
Aboody and her colleagues hadpreviously demonstrated the technique’sefficacy in primary and metastatic tumorsin the brain. This research is the first todemonstrate that the technique also iseffective in a metastatic cancer model,targeting many solid tumor sites spreadthroughout the body.
They believe that the technique couldalso be applied to other malignant solidtumors, including colon, brain, prostate andbreast cancers, and are planning preclinicaltrials using those tumors.
The research was funded by grants fromthe National Cancer Institute, the STOPCANCER Foundation, the Phi Beta PsiSorority, The Rosalinde and Arthur GilbertFoundation, theNeidorf FamilyFoundation, theMarcusFoundation andALSAC(AmericanLebanese SyrianAssociatedCharities). � � �
MA
RKIE
RA
MIR
EZ
� Karen Aboody
30 I CITY NEWS SUMMER 2007
RE
SE
AR
CH
A
ND
T
RE
AT
ME
NT
RIGHT ON TARGETResearchers find new ways to improve chemotherapy
R1_60085.Reader Spreads_Final 8/29/07 9:48 AM Page 32
GR
AN
TS
A
T
A
GL
AN
CE
City of Hope is a nationally recognized leader in biomedicalresearch. The institution ranked in the top 5 percent amongindependent research institutes in total grants awarded by theNational Institutes of Health, or NIH, in 2006. Following is aroundup of some notable grants awarded recently.
> Ralph M. ParsonsFoundation fundsteaching laboratory
The Ralph M. ParsonsFoundation has awarded
a $750,000 grant to
establish the Ralph M.
Parsons Teaching
Laboratory at the
City of Hope Graduate
School of Biological Sciences.
The teaching laboratory, which
will enhance educational
offerings for students in the
graduate school and the
Eugene and Ruth RobertsSummer Student Academy at
City of Hope, will be located on
the first floor of the Arnold andMabel Beckman Center for
Cancer Immunotherapeutics
and Tumor Immunology.
> UniHealth Foundationaward supports nurseeducation and trainingprogram
UniHealth Foundation has
awarded a three-year,
$511,130 grant to develop
evidence-based practice skills
in staff nurses, which will
promote patient safety and
quality nursing care. The
program will foster clinical
excellence and quality of care,
as well as the professional
development of future nurse
leaders. The mission of the
UniHealth Foundation is to
support and facilitate activities
that significantly improve the
health and well being of
individuals and communities
within its service area.
> Henry L. GuentherFoundation aids acquisition of 3T MRI machine
The Henry L. GuentherFoundation awarded a
two-year, $500,000 grant
to help City of Hope acquire
a 3-tesla magnetic resonance
imaging (MRI) machine. The
3T MRI will provide highly
precise imaging capabilities
to physicians and researchers,
enabling more accurate
diagnosis and better
treatment of solid tumors.
The equipment will be housed
in City of Hope Helford
Clinical Research Hospital.
> W.M. Keck Foundationsupports lymphoma study
The W.M. Keck Foundation has
awarded a one-year, $450,000
grant to support the study of
molecular mechanisms
underlying cancer and to
develop therapies that destroy
lymphoma cells without harming
normal cells. Stephen J. Forman,
M.D., Francis and Kathleen
McNamara Distinguished Chair in
Hematology and Hematopoietic
Cell Transplantation, leads the
pilot study, which will include a
team of investigators from
City of Hope and the California
Institute of Technology.
> The Rosalinde and ArthurGilbert Foundation continuesstem cell research support
The Rosalinde and Arthur
Gilbert Foundation awarded
$150,000 for a one-year grant
to support the stem cell
Targeting Project led by Karen
S. Aboody, M.D., assistant
professor in the divisions of
Neurosciences and Hematology
& Hematopoietic Cell
Transplantation, and Chu-Chih
Shih, Ph.D., assistant professor
in the Division of Hematology
& Hematopoietic Cell
Transplantation. The project
investigates the ability of stem
cells to migrate toward human
glioma cells and other tumors.
The foundation has now
supported the program for
three years. � � �
CITY NEWS SUMMER 2007 I 31
R1_60085.Reader Spreads_Final 8/29/07 9:48 AM Page 33
A COMMITMENT TO
HELPINGOTHERSGenerous philanthropists whosupport City of Hope hail fromdifferent backgrounds. A variety ofcreative giving options, including life estate planning, IRA beneficiarydesignation and gift annuities, makeit easy for them to find a custom-fitfinancial strategy for fighting life-threatening diseases.
Hands-on philanthropy A results-oriented entrepreneur,Larry Flax typifies today’s high-profile philanthropist. As a co-founder of California PizzaKitchen, Flax knows a thing or twoabout getting involved firsthand inassembling the right ingredientsand team. He believes the same istrue for supporting worthwhilecauses. “People can watch theirgood do good by becomingpersonally invested,” said Flax.
When Flax and his wife, Joni,recently considered theircharitable giving options, they
chose City of Hope because of the leadership shown by Michael C.Jensen, M.D., co-director of the Cancer Immunotherapeutics &Tumor Immunology program (CITI), and the institution’s advancesagainst brain cancer. Jensen’s engineered T-cell therapies, whichboost the immune system to attack cancer, are pushing researchboundaries, moving ever closer to achieving cures. Eager to spurthe discovery of new treatments for brain cancer in children, theFlax family has provided significant funding in recent years to aidJensen’s efforts, enhancing the pool of funds they have dedicated topediatric research at City of Hope since 1992.
Flax notes that today’s health-care philanthropists want toknow that their money truly advances and delivers improvedtreatments. In this vein, Flax has joined a new consortium ofmodern donors to pool their enthusiasm and knowledge in order tobest manage philanthropic giving. “I want to help superchargephilanthropy to maximize its impact,” Flax said.
Instead of making charitable gifts through bequests, “I wouldurge people to consider life estate planning that works for themduring their lifetime,” said Flax. “There certainly are worthwhile taxbenefits. Plus, you can manage your own gift and see how it ismaking a difference.”
Flax’s personal connection to research at City of Hopemotivates his desire to change the face of philanthropy, and hewould not have it any other way. “At City of Hope, you can be intouch with your gift and see what they’re doing.” This satisfactiongives new meaning to the term “hands-on control.”
Larry and Joni Flax live in Beverly Hills, Calif. Joni’s son, PeterGillette, and his wife, Michelle, have two children, Alex and Avery. � � �
By Carmen R. Gonzalez
Joni and Larry Flax�
GI
FT
P
LA
NN
IN
G
32 I CITY NEWS SUMMER 2007
R1_60085.Reader Spreads_Final 8/29/07 9:48 AM Page 34
A philanthropic visionaryTennessee resident CanoOzgener may be described as a man of tenacity anddetermination. Theseadmirable qualities served himwell during his career as amechanical engineer, andduring his first battle withlymphoma in 2000.
Not long before Ozgenerwas diagnosed withlymphoma, his good friendand Nashville Symphonyconductor KennethSchermerhorn already was
battling cancer. At a charity event, Ozgener met philanthropistMichael Milken, and they discussed Schermerhorn’s condition,prompting Milken to recommend City of Hope to Ozgener’s long-time friend. Later, when Ozgener’s own lymphoma recurred, herecalled Milken’s advice. “It was karma. God was showing me theway,” said Ozgener.
Once Ozgener arrived on campus, he met with Stephen J.Forman, M.D., Francis and Kathleen McNamara DistinguishedChair in Hematology and Hematopoietic Cell Transplantation, aphysician he feels embodies the institution’s renowned patient-centered philosophy. Inspired by the treatment he received,Ozgener praised all of those who cared for him. “Dr. Formangives confidence to patients and staff,” he said. “All thepersonnel are professional, caring, kind, compassionate — all of them.”
After his experience, Ozgener and his wife, Esen, weremotivated to find a way to support City of Hope. “We wanted todo even more to find a cure and reduce the suffering of all thoseaffected by cancer,” explained Ozgener.
The Ozgeners’ vision of helping to further better therapiesincluded making a significant gift to the institution. “I’mconvinced that with proper funding and research, one day we will win the fight against cancer,” said Ozgener.
The Ozgeners, who reside in Nashville, still travel to City of Hope, where Cano Ozgener continues his treatment. Hiscompassion also reaches beyond City of Hope, as he raises fundson behalf of the Michael Milken Foundation to support medicalresearch for prostate cancer.
“Making a gift through an IRA was easy,” noted Ozgener. “Theexpertise of the gift planning officers at City of Hope enabled meto choose the gift vehicle that best met my needs.” � � �
Esen and Cano Ozgener�
A show of brotherly loveJohn Click knew that he would keep a promisehe made to his latebrother, David. In the mid 1990s,
David was stricken with esophageal cancer.Frustrated by thebureaucratic andimpersonal medical care provided for hisyounger brotherelsewhere, Click directedhim to City of Hope for treatment.
After a prolonged struggle with the disease, David died. Throughout David’s stay at City of Hope, he told Click
that he did not feel like he was in a hospital, but instead felt athome and comforted. Click recalled fond memories about thethoughtfulness of the nurses and physicians who cared for hisbrother, including I. Benjamin Paz, M.D., director of theDepartment of General Oncologic Surgery.
“We lived in Desert Hot Springs back then, so ourcommute was long. Dr. Paz would take that into accountwhen scheduling treatments, making sure we’d avoidtraffic,” Click said. He also remembered his brother’sinstructions to someday contribute to City of Hope tosupport the institution.
Click made good on his promise. He began by makingCity of Hope the beneficiary of his IRA in 1997. Then, afterselling his home in 2006, Click donated $200,000 to City of Hope through a gift annuity, which produced annualincome. Not only did he honor his brother’s wishes, but hemade a smart financial move as well. “It was a good deal forme. I earn 8 percent a year for life, and it has tax advantages,too,” he said.
The donation to City of Hope will benefit crucialresearch into serious diseases, which pleases Click.“Maintaining research is important,” he said. “That’s whatmight produce the next cure.” And because his gift annuityis unrestricted, the institution may apply the funds to wherethey can do the most good.
The 80-year-old John Click resides in Calimesa, Calif.He grew up in Lone Pine, Calif., and enjoys many interestsrelated to mountain life. His hobbies include racing cars.His favorites are the 1932 and 1936 model Fords. � � �
CITY NEWS SUMMER 2007 I 33
John Click�
JOH
N C
LIC
K
JOH
N C
HIA
SSO
N
R1_60085.Reader Spreads_Final 8/29/07 9:48 AM Page 35
Office product industry leaders continuetheir steadfast support of City of Hope.The Paper Mate, Parker and Rolodexbrands in the Sanford, a NewellRubbermaid Company, family collectivelypledged to raise $270,000 for theinstitution through the end of 2008. 3M has raised more than $800,000 since 2004
via its Post-it Super Sticky Notes “StickUp for the Cause” campaign, including a $100,000 sponsorship of City of Hope’sWalk for Hope to Cure Breast Cancer, and its “Clean up for the Cause with O-Cel-O” scrub sponges program. Anotherindustry luminary, Staples, has raised
more than $1 million throughcause-related marketing during thelast two years with in-store,scratch-card coupons. Through its “Rock the Cure”
campaign, high-end fashionlabel Rock & Republic willdonate a minimum of 75 percent of profits fromspecial-edition jeans and T-shirts from June 2007 to June 2008 to benefitCity of Hope’s geneticresearch, treatment and education efforts.Sold in major upscale
retailers nationwide, additional productsare slated to be added to the campaign in 2008.
“American Idol”contestantSherman Pore,64, won fanswhen he recentlyauditioned forthe populartelevision showand shared the touching story of losing hispartner to ovarian cancer. Following hisappearance, Pore recorded the CD “For MyLady Love,” now available at storesnationwide, such as WalMart andWalMart.com. Pore’s label, Z-Entertainment, will donate $1 fromeach CD to City of Hope for cancerresearch, treatment and education. “ForMy Lady Love” includes classic love songssuch as “You Belong to Me” and“Unforgettable” and was recorded inCapitol Records Studio B, where bothFrank Sinatra and Dean Martin oncecrooned many standards. For moreinformation, visit shermanporeidol.com.
A number of beauty productscompanies are launchingcampaigns to benefit City of Hope. Conair will make a one-time charitablecontribution of $45,000 insupport of the institution’sbreast cancer research,treatment and educationefforts through its Jilbère de Paris brand’s“Pink Collection” hair products. ZotosInternational is donating $35,000 andpromoting City of Hope through its Zotosand Joico beauty and hair product brands.And Ergo will donate $15,000 through its“ProSleeker1” flat iron. � � �
Through cause-related marketing programs, City of Hope’s dedicated corporate supporters have helped raise
more than $25 million since 1999. These programs generate considerable national awareness and enhance
community support for our mission to eradicate life-threatening diseases. We thank all of the companies that
support our lifesaving research, treatment and education efforts through cause-related marketing campaigns.
COMPANIES ALIGN WITH CITY OF HOPE TO SAVE LIVES
CA
US
E
FO
R
HO
PE
34 I CITY NEWS SUMMER 2007
Subscribe to eHope, our monthly online newsletter, by visiting www.cityofhope.org/newsletters.
Once you submit your e-mail address,we’ll place you on our list.
Get the latest news aboutCity of Hope with just a click of your mouse.
R1_60085.Reader Spreads_Final 8/29/07 9:48 AM Page 36
CAROL RAMNARINE
I did not realize the importance of my treatment at first.
Clad in little more than a hospital gown, I approached the TomoTherapy HI-ART System with as much calm as an apprehensiveperson being fed into a radioactive machinecould muster in a situation like that.
Eventually, though, the magnitude of the event dawnedon me.
I was the first multiple myeloma patient in the world togo through total marrow irradiation. Two years of plannedresearch by the City of Hope TomoTherapy team was aboutto come together for the first time on a patient: me. I silentlyprayed, dedicating my participation to my father, William L.Grover, M.D., in addition to asking God’s steadfast hand tobless this team.
The TomoTherapy system is a specialized machine thatfocuses radiation treatment on a tumor site with little spill-over into the healthy tissue that surrounds it. Less but moreprecise radiation offers the potential benefit of lesseneddebilitating side effects. Total marrow irradiation meant theyhad to administer radiation to the bone marrow throughoutmy body.
The physicians made adjustments. Shifts were made inthe fabric and laser beams aligned to tattooed marks on mybody; shoulder straps and a face mask were put into place.Attention to details was evident; accuracy was paramount.The art of precision prevailed over the chatter of excitement.
Once they aligned the machine, my treatment began. First,a red light appeared, and then I heard a sound similar to awashing machine, or a marching band, drumming in a rhythmthat drowned out the music piped into the treatment room.
I held still. I did not want to move and cause them tostart all over. I escaped into my imagination as I lay there. Thedrumming sound of the machine melted into the snow-ladenstreet I raced down on my red wooden bobsled with mysiblings and friends on Crofton Road in Garfield Heights, Ohio.
The last 27 minutes of the procedure were the mostdifficult for me. I no longer was able to entertain my mind. I began to feel the fatigue of remaining still and lying on aplatform. I felt like the kid who kept asking her parents, “Arewe there yet?” The minutes and seconds ticked away slowly,but the terrific staff kept me motivated and resolved until the end of each treatment.
Each evening, before I was taken back to my room, myteam of doctors would see how I was handling thetreatment. I experienced minimal side effects; nothing wasas severe as the effects I saw in other patients who receivedtraditional radiation treatment.
Nearly two years have passed since then, and I amdoing great. This noninvasive radiation therapy, with fewerside effects, is amazing. I now volunteer my time at City of Hope mentoring other patients through their owncancer experiences, and also with the nonprofit Firefighter Cancer Support Network.
I am grateful to the people who have acted on theirdreams and dedicated their time, as well as the investors in research who have enabled so many great advances incancer treatment. I am truly blessed with a professionalmedical team and a fellowship of friends and family all supporting me. � � �
FI
RS
T P
ER
SO
N:
PA
TI
EN
T P
RO
FI
LE
First, butnot last
CITY NEWS SUMMER 2007 I 35
�Carol Ramnarine with her beloved pets
R1_60085.Reader Spreads_Final 8/29/07 9:48 AM Page 37
36 I CITY NEWS SUMMER 2007
On a minute scale, stem cells do thesame for their chromosomal DNA, fixingsplits and breaches in it. But how well dothey do it?
A noted City of Hope investigatorwants to find out.
Timothy O’Connor, Ph.D., professor inthe Division of Biology, was recentlyawarded one of the first grants to fundhuman embryonic stem cell researchresulting from passage of California’s Proposition 71, also known as the CaliforniaStem Cell Research and Cures Initiative.The grant funds his work in DNA repair.
O’Connor shared the honor with Prop.71 investigators statewide, accordingto the California Institute for RegenerativeMedicine (CIRM). These SEED (forScientific Excellence through Explorationand Development) grants are awarded toexperts working outside the embryonicstem cell field in the hope that they bringnovel insight to stem cell biology.
For 20 years, first at the InstitutGustave Roussy in Villejuif, France, and inthe last 10 at City of Hope, O’Connor hasidentified proteins that repair nicks andbreaks in chromosomal DNA. “We areinterested in how cells protect themselvesfrom DNA damage, and how thosestrategies can be exploited for possible
therapy,” he said. Breaks in double-helical DNA strands
occur following exposure to mutagens orradiation and much less frequently duringnormal cell division. Healthy cells expresslegions of proteins whose job is to repairbattered DNA. Without them, cells can dieor become cancer cells.
Although the amount is not yet finalized,the CIRM governing board will awardO’Connor about $350,000 over two years todetermine how efficiently DNA repairproteins operate in human embryonic stem,or ES, cells. Funds will support specialistswho know how to make finicky stem cellsthrive in a Petri dish. “ES cells take a lot ofcare and feeding,” explained O’Connor.
Steven Bates, a senior research associateat City of Hope since 1992, will handle thecells’ care. Bates devised a unique method toprepare “feeder” or support cells used tomaintain ES cells in culture.
Some studies suggest that over longperiods, ES cells accumulate mutations, orerrors in their DNA sequence, more readilythan other cells. “Our goal is to try tounderstand if repair processes differ atthese very early stages of developmentfrom repair processes operating in cells thathave developed into more mature celltypes,” O’Connor said.
One technique O’Connor will use toaccomplish that is to mutate a geneencoding a protein called luciferase, whichemits light. The scientist then forces that
nonfunctional luciferase gene into an ES celland waits to see if it will glow. “After differenttime points, say eight to 48 hours, we canstart to see a signal — that’s an indicationthat repair has occurred,” O’Connor said.Researchers then will compare the repair rateto that in non-ES cells.
O’Connor says that scientists mustdetermine how vulnerable human ES cells areto DNA damage before they are infused intopeople as replacement therapies. “It is notyet clear what will happen when you put aliving stem cell into a person, so it is veryimportant to understand what that cell isdoing. It’s not like a drug that you can stopgiving to someone,” O’Connor said.
The hope is that tissues derived fromstem cells will last a lifetime. O’Connor’swork is aimed at making sure that ES cellreplacement therapy is a good thing. � � �
Timothy O’Connor
�
MA
RKIE
RA
MIR
EZ
RE
SE
AR
CH
A
ND
T
RE
AT
ME
NT
A shaving nick. A burn from a hot oven. A bruise from an unintendedmeeting of shin against coffee table. A parade of damaged tissue —tissue that is injured, heals and turns whole again.
City of Hope investigator receives one of California’s
FIRST HUMAN STEM CELL GRANTSBy Elise Lamar
R1_60085.Reader Spreads_Final 8/29/07 9:48 AM Page 38
CITY NEWS SUMMER 2007 I 37
Campos and Ruble had reason fortheir deep emotions: For the first time, theygot to meet the generous bone marrowdonors who helped save their lives whenthey were desperately ill with leukemia.
The donors and recipients met at the31st annual “Celebration of Life”hematopoietic cell transplantation (HCT)reunion on April 27 on the Duarte, Calif.,campus. They were joined by nearly6,000 HCT recipients, their loved onesand caregivers, who gather each year forthe event, a City of Hope tradition.
While the success stories changeevery year, attendees at the highlyanticipated HCT reunions appreciateevery one, knowing how hard those canbe to come by.
“We do this year after year, and itnever gets old — there are always newstories of courage and hope in ourpatients,” said Stephen J. Forman, M.D.,Francis and Kathleen McNamaraDistinguished Chair in Hematology andHematopoietic Cell Transplantation andclinical director of the Division of CancerImmunotherapeutics & TumorImmunology, before introducing Camposand Ruble to their donors at a morningpress conference.
The experience is even morepowerful for the patients themselves.
“It’s like a family reunion,” saidformer patient Jeff Maurer, a SouthernCalifornia firefighter who is a two-timecancer survivor. “Every year, I see a lot ofpeople with the same stories as me whoare living healthy and full lives followingtheir transplant.”
The event also raised awarenessabout the need for hematopoietic cell
donation. Assemblyman AnthonyPortantino (D-Pasadena) spoke at a pressconference during the event about a billhe backs that would create a statewidepilot cord blood collection program. Theprogram would improve the chance of amatch for people who need transplantation.
“Umbilical cord blood, which 90 percent of the time gets thrown in thetrash, cures 70 diseases,” Portantino said.
Arizona patients reunite, celebrate
More than 200 former patients and lovedones gathered with physicians, nursesand other caregivers at the City of Hope-Banner Bone Marrow Transplant (BMT)Program’s 10th anniversary reunion, heldMay 18 at the Phoenix Art Museum.
The City of Hope-Banner BMT Program,formerly known as the City of Hope-Samaritan BMT Program, performedmore than 660 transplants in its firstdecade. (The program’s name wasrecently changed to better reflect the twoparent organizations.) The program alsohas accommodated almost 29,000outpatient visits, making a profounddifference in the lives of people in thePhoenix area and beyond. Patients in theprogram have come from 10 states andseven countries.
“Our program has grown significantlyfrom our opening 10 years ago, and manyimprovements in the care we are able toprovide are on the horizon,” said JeffreySchriber, M.D., medical director of theCity of Hope-Banner BMT Program. “Wehave built a program where patients fromthe Phoenix area can be transplantednear their homes, and we have alsoworked diligently to advance cancertreatment.” � � �
By Kathleen O’Neil and Alicia Di Rado
An overwhelmed Cindy Campos, age 10, cried when Doug Baxter, aCanadian airline pilot, knelt to give her a hug. Architect John Ruble’svoice cracked as he strained to hold back tears when he saw GregShaver, a young man from Indiana.
REUNIONScelebrate thousands of lives saved through transplantation
AM
YCA
NTR
ELL.
CO
M
Survivors shared laughter, hope and storiesfrom their lives at the 2007 “Celebration ofLife” reunion on April 27 in Duarte, Calif.
�
BEN
ARN
OLD
Former patient Nathanael Buus, right, hugshis marrow donor, Justin Chaney, at the City of Hope-Banner Bone Marrow TransplantProgram’s 10th anniversary reunion, held onMay 18 in Phoenix.
�
R1_60085.Reader Spreads_Final 8/29/07 9:48 AM Page 39
Each year, hundreds offundraising events heldacross the country raisemillions of dollars tosupport vital research,treatment and educationprograms at City of Hope.In this column, wehighlight a few of themajor fundraisingactivities that have taken place during the past few months.
Celebrating FUNDRAISING EVENTS
38 I CITY NEWS SUMMER 2007
Real estate industry memberMatt Hoffer (above) lent histalent for the 13th annual RealEstate Action Committee for City of Hope’s (REACH) Socialat House of Blues in Chicagoon April 26. Hoffer competed for a spot as the lead singer of a supergroup on the 2006CBS reality series “Rock Star:Supernova.” More than 1,200supporters gathered at theREACH event, which raisedmore than $300,000 to benefitCity of Hope’s pediatric cancerresearch, treatment andeducational programs andfeatured musicians from thelocal construction and realestate industries, along withguest musician Rick Nielsenfrom ‘80s band Cheap Trick.Since its founding in 1996,REACH has raised more than$1 million for City of Hopeprograms. The committee hasgrown to include professionalsfrom many ancillary industriesincluding construction,brokerage, architecture, financeand building maintenance. � � �
Michael C. Jensen, M.D., co-director of the CancerImmunotherapeutics &Tumor Immunology programand director of pediatricneuro-oncology (left),congratulates honoree FrankL. Rollo, principal ofTreadwell & Rollo, at theNorthern California RealEstate and Construction(REC) Business Alliance’sannual Spirit of Life® AwardDinner. Held on May 10 inSan Francisco, the festive galaattracted more than 600 supporters, who alsocelebrated the REC’s annualfundraising total of $390,000— an amount that exceededthe group’s 2007 goal bymore than 10 percent. Rollohas served as seniorgeotechnical consultant forthe development of MissionBay, Embarcadero Center and many other high-risebuildings throughout the BayArea and California. � � �
Supporters teamed up forthe Southwest FoodIndustry’s Spirit of HopeGolf Tournament, held atthe Camelback Golf Club inScottsdale, Ariz., on April 27.From left, Dan Valenzuela,president, Safeway PhoenixDivision; Nikki Daly, director,Public Affairs andGovernment Relations,Safeway Phoenix Division;Frank Cannistra, vicepresident, Retail Operations,Safeway Phoenix Division;and Frank Conley, vicepresident, Finance, SafewayPhoenix Division. Presentedby Miller Brewing Company,the annual event attractedmore than 700 supporters,who helped raise more than$490,000 through thetournament, as well as adinner and silent auction on April 28. � � �
Ben “Clevelander”Cleveland from Equis laysa punch on MaxChopovsky of Grubb &Ellis at the fifth annualBroker Boxing Federation(BBF) event, held May 10 at the HotelInterContinental inChicago. This year’s 10-bout fight card, whichdrew a capacity crowd of more than 1,200supporters, includedrepresentatives fromcompanies such as Equis,NAI Hiffman, Grubb & Ellis and Junipar. The mission of the BBF,founded in 2003 by Eric Nixon of the MaronNetwork and DavidGoldberg of Newmark, isto bring the Chicago realestate communitytogether once a year toraise money for localcharities. This year’spugilistic event raisedmore than $275,000 forCity of Hope. � � �
CI
TY
O
F
HO
PE
E
VE
NT
S
CLA
IRE
BOC
K
MA
IN P
HO
TO A
ND
PH
OTO
AT
LEFT
BELE
N A
QU
INO
/ G
ERBE
R &
SCA
RPEL
LIPH
OTO
GRA
PHY
DIG
ITA
L M
OTO
PH
OTO
R1_60085.Reader Spreads_Final 8/29/07 9:48 AM Page 40
A recent study by Jeffrey Weitzel,M.D., director of the Departmentof Clinical Cancer Genetics, andhis colleagues, which found thatwomen who don’t have manyolder female relatives on one sideof their family may carry a BRCAgene mutation without realizingit, was featured in numerousnational publications. (BRCAmutations are linked to variouscancers, including breast cancer.)Publications and news outletscovering the story included TheNew York Times, The Wall StreetJournal, Washington Post, LosAngeles Times, U.S.News &World Report.com, TIME.com,Forbes.com, BusinessWeek.com,Associated Press, Reuters, UnitedPress International, ScientificAmerican, Miami Herald, ThePhiladelphia Inquirer and theChicago Tribune, among others.The study was also featurednationally by CBS affiliates,including KCBS and KCAL-TV in Los Angeles. The study waspublished in the Journal of theAmerican Medical Association.
A June 11 Los Angeles Timesstory quoted Sunita Patel, M.D.,assistant professor, Division ofPopulation Sciences, and YunYen, M.D., Ph.D., associatedirector of translational research,on findings from the 2007American Society of ClinicalOncology (ASCO) conference,including therapies for treatingliver cancer and a drug to reducethe cognitive side effects ofchemotherapy.
A June 22 segment on “GoodMorning America” highlighted“Hannah Montana” actressMiley Cyrus and her upcoming
concert tour, with a dollar fromeach ticket sold benefiting City of Hope.
The Los Angeles Times featured a lymphoma Q&A on April 23with Mark Kirschbaum, M.D.,director of new drugdevelopment and assistantprofessor in the Division ofHematology & HematopoieticCell Transplantation.
The May issue of Los Angelesmagazine included an articleabout private support’sincreasing role in fundinginnovative biomedical studies.The story cited City of Hope asone of Southern California’sworld-class research facilities.
OK! Magazine highlightedentertainer Sheryl Crow on April30 for her various charitablecontributions, including publicservice announcements sherecorded for City of Hope toraise cancer awareness.
On April 28, City of Hope’s 31stHematopoietic Cell TransplantationReunion was featured on thefront page of the Pasadena Star-News and also was coveredby the San Gabriel ValleyTribune, Whittier Daily News,
Inland Valley Daily Bulletin, SanBernardino Sun and KABC-TV.Newspapers covering eventparticipants also included theCalgary Sun on April 13, theWinnipeg Free-Press on April 27,the North County Times on April 28 and Today’s Local News(San Diego) on April 29.
The San Diego Union-Tribunereported on April 24 that Gail K.Naughton, Ph.D., was appointedto City of Hope’s national boardof directors.
On March 19, TheAssociated Pressran a story aboutthe planned
retirement of Ronald Shaw,president and chief executive
officer of Pen Pilot. In the article,Shaw said that after retirement,he will continue supporting City of Hope.
The Summit, a businessmagazine supplement in thePasadena Star-News, SanGabriel Valley Tribune, WhittierDaily News and Inland ValleyDaily Bulletin, quoted RobertFiglin, M.D., the Arthur andRosalie Kaplan Professor ofMedical Oncology, and chair ofthe Division of Medical Oncology& Therapeutics Research, in a March 30 story about City of Hope’s global and localimpact. City of Hope also waslisted in the magazine as one ofthe largest organizations in the San Gabriel Valley. � � �
These are just a few of the City of Hope developments that have been
MAKING NEWS ACROSS THE COUNTRY
IN
T
HE
N
EW
S
CITY NEWS SUMMER 2007 I 39
Sheryl Crow
�
R1_60085.Reader Spreads_Final 8/29/07 9:49 AM Page 41
To find out about events taking place across thecountry that support City of Hope, visit our Web siteat www.cityofhope.org/calendar. For details aboutactivities happening in your area, please contact yournearest City of Hope Regional Development Office.
CITY OF HOPE MEDICAL CENTER800-423-7119
PATIENT REFERRAL LINE(for patient referral inquiries)800-826-4673
GIFT PLANNING800-232-3314
CITY OF HOPE REGIONAL DEVELOPMENT OFFICES:
LOS ANGELES DEVELOPMENTHEADQUARTERS800-544-3541
MIDWEST REGION Chicago Regional Headquarters800-779-5893
NORTHEAST REGIONPhiladelphia Regional Headquarters
800-344-8169
NORTHWEST REGIONSan Francisco Regional Headquarters
800-732-7140
Seattle Office 800-934-9196
SOUTHEAST REGIONFlorida Office (Fort Lauderdale)800-584-6709
SOUTHWEST REGIONLos Angeles DevelopmentHeadquarters
800-544-3541
Desert Communities Office(Cathedral City, Calif.)800-732-7121
Phoenix Office 800-732-7309
San Diego Office 888-805-8911
NUMBERST O K N O W
40 I CITY NEWS SUMMER 2007
By H. Chung So
Many factors influence well-being,but daily habits can play a role insafeguarding health and evenlowering the risk of cancer and otherdiseases. This column includes tipsfrom City of Hope experts on makinggood lifestyle choices.
> Should you consider genetic testing? In a study published in a June issue of theJournal of the American Medical Association,City of Hope researchers found that womenwith early breast cancer (those diagnosedyounger than 50 years of age) who have fewfemale relatives on either side of their familytree should consider genetic testing formutations in the BRCA genes. The study foundthat these women are three times as likely tohave such a mutation, compared to womenwith sufficient family history to showa familial pattern of breast cancer.BRCA gene mutations are linkedto an increased risk of recurrentbreast cancers, as well asovarian and fallopian tubecancers. By detectingthese mutationsthrough genetictesting,women canconsidervariouspreventativeand screeningoptions tominimize those risks.
> Is hormone replacement therapy (HRT)okay? An April study in the New EnglandJournal of Medicine and a July study in theBritish Medical Journal suggested that hormonereplacement therapy (HRT) may be tied toincreased risks of breast cancer and
cardiovascular disease. However, researcherstied to both studies noted that women can stilluse HRT to alleviate menopause symptoms,
but recommended using the lowest possibledose for the shortest period of time.
> Do fruits and veggies really keepyou healthy? September is Fruit and
Vegetable Month, and the Centers forDisease Control and Prevention
(CDC) encouragesAmericans to eat more
fruit and vegetables tomanage weight andreduce risk of diabetes,
heart disease and certaincancers. For more
information about thehealth benefits of these foods
and tips on incorporating them into meals andsnacks every day, visit the CDC’s “Fruits &Veggies Matter” Web site atwww.fruitsandveggiesmatter.gov.
>Before making significant lifestyle changes,consult with your physician.
C A L E N D A R
S TAY I N G I N TO U C H
You may have received this fundraisingcommunication because you previouslyreceived services at City of Hope NationalMedical Center. If you do not wish to receivesuch communications in the future, send awritten request to the following address:
City of Hope1055 Wilshire Blvd.Los Angeles, CA 90017Attn.: Publications Manager,
Communications
An ounce of prevention> Does depression in theelderly contribute todiabetes? A recentlypublished analysis of more than4,500 men and women 65 orolder across the nation revealedthat chronic depression and depression
that worsens over time is tied to ahigher chance of developing diabetes— even after accounting for
contributing lifestyle factors such asdiet and exercise. Because diabetes istied to conditions such as stroke, heartdisease, kidney failure and blindness,the study’s researchers suggest that
older Americans should be screenedfor both depression and diabetes.
R1_60085.Reader Spreads_Final 8/29/07 9:49 AM Page 42
Cards for Hope showcase City of Hope’s beautiful grounds and provide the
recipient with the stories behind many of the institution’s historical landmarks.
Each unique card informs the recipient that a donation has been made to City of Hope in his
or her name. Select a card that conveys your special message. Your generous contribution will help
City of Hope win the fight against cancer and other life-threatening diseases.
Celebrate
Get Well In Loving Memory
Thinking of You Thank You
Blank
In Cherished Memory
For more information, call 877-302-4673, ext. 62635, or visit us onlineat www.cityofhope.org/cardsforhope.
A contributor envelope is included in this publication for yourconvenience so that you can send your special message right away.
Cards for HopeNew
Designs
R1_60085.Reader Spreads_Final 8/29/07 9:49 AM Page 43
Nonprofit
Organization
U.S. Postage
P A I D
Los Angeles, CA
Permit No. 5004
D E L I V E R T O :
J02-13475.ap.Summer07.120M
If your address is incorrect, or you are receivingduplicate copies of this publication, pleaseupdate the label and mail to City News, 1055Wilshire Blvd., Los Angeles, CA 90017. You canalso call 800-544-3541, ext. 26120, or [email protected]. By giving the code numberthat appears above your name, your requestcan be processed quickly. Thank you forhelping us to be more efficient incommunicating how your support is touchingmillions of lives.
TO CONTACT US
1055 Wilshire BoulevardLos Angeles CA 90017800-260-HOPE (4673)[email protected]
E Printed on recycled paper
www.cityofhope.org
Specifics and Benefits:• Must be age 70 1/2 or older.• You can donate up to $100,000 per year in 2007.• Your donation may be counted toward the required minimal distribution for tax-deferred
retirement accounts in the year the gift is made.• The IRA Charitable Rollover applies to outright gifts only.• A gift from your IRA will not generate federal taxable income or a tax deduction.• It’s easy — Simply instruct your IRA custodian to transfer funds directly to City of Hope.
For further information, please contact the Gift Planning Department at 800-232-3314.
Individual IRA distributions can be subject to income tax as high as 35%.Additionally, if an heir inherits the IRA it may be subject to estate tax.
By making an IRA Charitable Rollover directly from your IRA to City of Hope,BOTH OF THESE TAXES CAN BE AVOIDED.
The new Pension Protection Act allows you to contribute part of your IRA to charitywithout paying federal income taxes on the withdrawal through December 31, 2007.*
Did you know that...up to 65 cents of every dollar in yourIndividual Retirement Account (IRA) may go to taxes?
*Confer with your advisor regarding your options as differing state tax laws may affect your plans.
www.cityofhope.org/giftplanning
R1_60085.Reader Spreads_Final 8/29/07 9:49 AM Page 44